Drug Sponsor |
Sponsor |
Medical Review |
Clinical Pharmacology Review |
Statistical Review |
BPCA or PREA or Both |
Abametapir - Xeglyze |
HATCHTECH PTY LTD |
Medical (PDF - 4 MB)
Addendum (PDF - 78 KB)
CDTL (PDF - 3 MB)
Resubmission (PDF - 77 KB)
DD (PDF - 2 MB)
|
Clinical pharmacology (PDF - 6 MB) |
Statistical (PDF - 207 KB) |
PREA |
Abacavir and Lamivudine - Epzicom |
ViiV Healthcare Company |
Medical (PDF - 3 MB) |
Clinical pharmacology (PDF - 158 KB) |
Statistical (PDF - 693 KB) |
PREA |
Abacavir, Dolutegravir, and Lamivudine - Triumeq |
ViiV Healthcare Company |
Medical (PDF - 443 KB) |
Clinical pharmacology (PDF - 128 KB) |
None |
PREA |
Abacavir, Dolutegravir, and Lamivudine - Triumeq
|
ViiV Healthcare Company c/o GlaxoSmithKline |
Medical (PDF - 389 KB)
CDTL (PDF - 798 KB)
|
Clinical pharmacology (PDF - 128 KB) |
None |
PREA |
Abacavir, Dolutegravir, and Lamivudine - Triumeq PD |
ViiV Healthcare Company |
CDTL (PDF - 758 KB) |
Clinical pharmacology (PDF - 3 MB) |
None |
BOTH |
Abacavir sulfate - Ziagen |
ViiV Healthcare Company |
Medical (PDF - 4.2 M B) |
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 5 MB) |
PREA |
Abatacept - Orencia |
Bristol-Myers Squibb Company |
Medical (PDF - 259 KB)
Medical Addendum (PDF - 469 KB)
|
Clinical pharmacology (PDF - 2 MB)
Clinical pharmacology (PDF - 269 KB)
|
None |
BOTH |
Abatacept - Orencia |
Bristol-Myers Squibb Company |
Medical (PDF - 4 MB) |
None |
None |
BPCA |
AbobotulinumtoxinA - Dysport |
Ipsen Bipharm Limited |
CDTL Review (PDF - 2 MB)
Medical (PDF - 3 MB)
|
None |
Statistical (PDF - 2 MB) |
PREA |
AbobotulinumtoxinA - Dysport |
Ipsen Bipharm Limited |
Medical (PDF - 1 MB) |
None |
Statistical (PDF - 857 KB) |
PREA |
Abrocitinib - Cibinqo
|
Pfizer Inc. |
Medical (PDF - 10 MB) |
None |
None |
PREA |
Abrocitinib - Cibinqo |
Pfizer Inc. |
Medical (PDF - 5 MB) |
None |
None |
PREA |
Acetaminophen - Ofirmev |
MallInc.krodt, Inc. |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 5 MB) |
Statistical (PDF - 378 KB) |
BOTH |
Acetylcysteine - Legubeti |
Galephar Pharmaceutical Research Inc. |
Unireview (PDF - 6 MB)
Unireview CR (PDF - 10 MB)
|
None |
None |
PREA |
Acyclovir 5%, hydrocortisone 1% - Xerese |
Valeant International Bermuda |
Medical (PDF - 885 KB) |
None |
None |
PREA |
Adalimumab-adaz - Hyrimoz
|
Sandoz Inc. |
Medical (PDF - 2 MB)
CDTL Review (PDF - 300 MB)
|
None |
None |
PREA |
Adalimumab-adaz - Hyrimoz
|
Sandoz Inc. |
CDTL Review (PDF - 342 KB)
|
None |
None |
PREA |
Adalimumab-adaz - Hyrimoz |
Sandoz Inc. |
CDTL Review (PDF - 34 KB) |
None |
None |
PREA |
Adalimumab-adbm - Cyltezo |
Boehringer Ingelheim |
Medical (PDF - 826 KB) |
None |
None |
PREA |
Adalimumab-afzb - Abrilada |
Pfizer Inc. |
CDTL (PDF - 34 KB) |
None |
None |
PREA |
Adalimumab-afzb - Abrilada |
Pfizer Inc. |
Medical (PDF - 1 MB) |
None |
None |
PREA |
Adalimumab-afzb - Abrilada |
Pfizer Inc. |
CDTL (PDF - 34 KB) |
None |
None |
PREA |
Adalimumab-aqvh - Yusimry |
Coherus BioSciences, Inc |
Medical (PDF - 5 MB) |
None |
None |
PREA |
Adalimumab-aqvh - Yusimry |
Coherus BioSciences, Inc |
CDTL Review (PDF - 342 KB) |
Clinical pharmacology (PDF - 22 KB) |
None |
PREA |
Adalimumab-atto - Amjevita |
Amgen Inc. |
CDTL Review (PDF - 4.3 MB)
Medical (PDF - 199K KB)
Medical (PDF - 336KB)
DD Summary Review (PDF - 3 MB)
|
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 416 KB)
Statistical (PDF - 363 KB)
Statistical (PDF - 717 KB)
|
PREA |
Adalimumab-aaty - Yuflyma |
Celltrion, Inc. |
CDTL - DD (PDF - 356 KB) |
Clinical pharmacology (PDF - 2 MB) |
None |
PREA |
Adalimumab-atto - Amjevita |
Amgen, Inc |
CDTL (PDF - 580 KB) |
None |
None |
PREA |
Adalimumab-atto - Amjevita |
Amgen, Inc |
Medical (PDF - 532 KB) |
None |
None |
PREA |
Adalimumab-atto - Amjevita
|
Amgen, Inc |
Medical (PDF - 532 KB) |
None |
None |
PREA |
Adalimumab-atto - Amjevita |
Amgen Inc. |
Medical (PDF - 25 KB) |
None |
None |
PREA |
Adalimumab-bwwd - Hadlima |
Samsung Bioepis Co., Ltd. |
Medical (PDF - 34 KB) |
Clinical pharmacology (PDF - 1 MB) |
None |
PREA |
Adalimumab-bwwd - Hadlima |
Samsung Bioepis Co., Ltd. |
Medical (PDF - 34 KB) |
None |
None |
PREA |
Adalimumab-fkjp - Hulio |
Mylan Pharmaceuticals Inc. |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Adalimumab-fkjp - Hulio
|
Mylan Pharmaceuticals Inc. |
Medical (PDF - 580 KB) |
None |
None |
PREA |
Adalimumab-fkjp - Hulio |
Mylan Pharmaceuticals Inc. |
CDTL (PDF - 24 KB) |
None |
None |
RPEA |
Adalimumab - Humira |
AbbVie,Inc. |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Adalimumab-aacf - Idacio |
Fresenius Kabi USA, LLC |
Medical (PDF - 20 MB) |
None |
None |
PREA |
Adalimumab-aacf - Idacio |
Fresenius Kabi USA, LLC |
Medical (PDF - 20 MB) |
None |
None |
PREA |
Adapalene and benzoyl peroxide - Epiduo |
Galderma Laboratories, LP |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF -124 KB) |
Statistical (PDF - 577 KB) |
PREA |
Adapalene and benzoyl peroxide - Epiduo Forte |
Galderma Research and Development LLC |
Medical (PDF - 6.2 MB) |
Clinical pharmacology (PDF - 4 MB) |
Statistical (PDF - 2 MB) |
PREA |
Afatini - Gilotrif
|
Boehringer Ingelheim Pharmaceuticals, Inc. |
Medical (PDF - 5 MB) |
None |
None |
BPCA |
Aflibercept - Eylea
|
Regeneron Pharmaceuticals, Inc. |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 2 MB) |
Statistical (PDF - 5 MB) |
BPCA |
Anidulafungin - Eraxis |
Vicuron Holdings LLC, a subsidiary of Pfizer Inc. |
Medical (PDF - 5 MB) |
None |
None |
PREA |
Albuterol and Budesonide - Airsupra |
Bond Avillion 2 Development LP |
Medical (PDF - 12 MB) |
None |
None |
PREA |
Albuterol sulfate - ProAir RespiClick |
Teva Pharmaceutical Products R. & D., Inc. |
Medical (PDF - 3 MB) |
Clinical pharmacology (PDF - 4 MB) |
Statistical (PDF - 2 MB) |
PREA |
Albuterol sulfate - ProAir RespiClick |
Teva Branded Pharmaceutical Products R&D, Inc. |
Medical (PDF - 859 KB) |
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 1 MB) |
PREA |
Alirocumab - Praluent |
Regeneron Pharmaceuticals, Inc |
Medical (PDF - 859 KB) |
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 1 MB) |
PREA |
Aliskiren - Tekturna |
Noden Pharma DAC |
CDTL (PDF - 310 KB) |
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 442 KB) |
BOTH |
Alogliptin - Nesina |
Takeda Pharmaceuticals U.S.A., Inc |
Medical (PDF - 6 MB) |
Clinical pharmacology (PDF - 937 KB) |
Statistical (PDF - 536 KB) |
PREA |
Alogliptin and metformin - Kazano |
Takeda Pharmaceuticals U.S.A., Inc. |
Medical (PDF - 6 MB) |
Clinical pharmacology (PDF - 937 KB) |
Statistical (PDF - 536 KB) |
PREA |
Amlodipine benzoate - Katerzia
|
Silvergate Pharmaceuticals, Inc |
Medical (PDF - 46 KB) |
Clinical pharmacology (PDF - 337 KB) |
None |
PREA
|
Amphetamine - Adzenys ER |
Neos Therapeutics, Inc. |
Medical (PDF - 1.9 MB) |
Clinical pharmacology (PDF - 4 KB) |
None |
PREA |
Amphetamine Extended-Release Orally Disintegrating Tablets - Adzenys XR-ODT |
Neos Therapeutics, Inc. |
Medical (PDF - 470 KB) |
Clinical pharmacology (PDF -3 MB) |
None |
PREA |
Amphetamine - Dyanavel XR |
Tris Pharma |
Medical (PDF - 1.8 MB) |
Clinical pharmacology (PDF - 5 MB) |
Statistical (PDF - 767 KB) |
PREA |
Amphetamine - Dyanavel XR |
Tris Pharma |
Medical (PDF - 848 KB)
CDTL Review (PDF - 1 MB)
|
None |
None |
PREA |
Amphetamine sulfate - Evekeo
|
Arbor Pharmaceuticals, LLC |
Medical (PDF - 1 MB)
Medical (PDF - 155 KB)
|
Clinical pharmacology (PDF - 9 KB)
Clinical pharmacology memo (PDF - 9 KB)
|
Statistical (PDF - 532 KB) |
PREA |
Apremilast - Otezla |
Amgen, Inc |
Medical (PDF - 7 MB) |
None |
None |
PREA |
Aprepitant - Emend |
Merck Sharp & Dohme Corp. |
Medical (PDF - 6 MB)
Medical Addendum (PDF -1 MB)
Medical DD memo (PDF - 3 MB)
|
Clinical pharmacology (PDF - 5 MB)
Clinical pharmacology addendum (PDF - 424 KB)
|
Statistical (PDF - 1 MB) |
PREA |
Aprepitant - Emend |
Merck Sharp & Dohme Corp. |
Medical (PDF - 553 KB) |
Clinical pharmacology (PDF - 5 MB)
Addendum (PDF -105 KB)
|
Statistical (PDF - 1 MB) |
PREA |
Aripiprazole - Abilify |
Otsuka |
Medical (PDF - 2.4MB) |
None |
Statistical (PDF - 409 KB) |
PREA |
Asenapine - Saphris |
Forest Laboratories, Inc. |
Medical (PDF - 5 MB)
Medical (PDF - 4 MB)
|
Clinical pharmacology (PDF - 4 MB) |
Statistical (PDF - 3 MB) |
BOTH |
Asparaginase erwinia chrysanthemi (recombinant)- rywn - Rylaze |
Jazz Pharmaceuticals Ireland Limited |
Medical (PDF - 4 MB) |
None |
None |
PREA |
Atazanavir and cobicistat - Evotaz |
Bristol-Myers Squibb Company |
CDTL (PDF - 402 KB) |
Clinical pharmacology (PDF -1 MB) |
None |
PREA |
Atazanavir - Reyataz |
Bristol-Myers Squibb Company |
Medical (PDF - 14 MB) |
Clinical pharmacology (PDF -1 MB) |
Statistical (PDF - 2 MB) |
BOTH |
Atazanavir - Reyataz |
Bristol-Myers Squibb Company |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF - 4 MB) |
BOTH |
Atezolizumab - TECENTRIQ
|
Genentech, Inc. |
Medical (PDF - 1 MB) |
None |
None |
BPCA |
Atezolizumab - Tecentriq
|
Genentech, Inc. |
Medical (PDF - 3 MB) |
None |
None |
BPCA |
Atorvastatin calcium - Atorvaliq |
CMP Development LLC |
Medical (PDF - 3 MB) |
Clinical pharmacology (PDF - 1 MB) |
None |
PREA |
Atropine-pralidoxime - DueDote
|
Meridian Medical Technologies, Inc. |
CDTL (PDF - 402 KB)
Medical (PDF - 886 KB)
|
Clinical pharmacology (PDF - 1 MB) |
None |
PREA |
Atropine Sulfate - Isopto Atropine 1% |
Alcon Research, Ltd. |
Medical (PDF - 663KB) |
Clinical pharmacology (PDF - 480KB) |
Statistical (PDF - 230KB) |
PREA |
Atropine Sulfate Ophthalmic Solution |
Akorn, Inc. |
Medical (PDF - 1.2 MB) |
Clinical pharmacology (PDF - 1MB) |
Statistical (PDF - 287KB) |
PREA |
Azelastine hydrochloride - Astepro |
Meda Pharmaceuticals |
Clinical (PDF -1 .4MB) |
None |
Statistical (PDF -473 KB |
PREA |
Azelastine hydrochloride - Astepro |
Meda Pharmaceuticals Inc. |
Medical (PDF - 2MB) |
None |
None |
BOTH |
Azelastine hydrochloride and Fluticasone propionate - Dymista |
Meda Pharmaceuticals, Inc. |
Medical (PDF - 2.9MB) |
None |
Statistical (PDF -2.1MB) |
BOTH |
Baclofen - Fleqsuvy |
Azurity Pharmaceuticals, Inc. |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 367 KB) |
None |
PREA |
Baclofen - Lyvispah |
Saol Therapeutics Research Limited |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 448 KB) |
None |
PREA |
Baloxavir marboxil - Xofluza
|
Shionogi, Incorporated
|
CDTL (PDF - 869 KB)
Medical (PDF - 414 KB)
|
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 2 MB) |
PREA |
Baloxavir marboxil - Xofluza |
Genentech, Incorporated |
CDTL (PDF - 853 KB)
Medical (PDF - 6 MB KB)
|
Clinical pharmacology (PDF - 420 KB) |
None |
PREA |
Baloxavir marboxil - Xofluza |
Genentech, Incorporated |
Medical (PDF - 11 MB) |
None |
None |
PREA |
Barium sulfate - E-Z-HD |
Bracco Diagnostics Inc. |
Medical (PDF - 2.4MB) |
Clinical pharmacology (PDF -642KB) |
Statistical (PDF -988KB) |
PREA |
Barium sulfate - READI-CAT 2 & READI-CAT 2 SMOOTHIE |
Bracco Diagnostics |
Medical (PDF - 2.4MB) |
Clinical pharmacology (PDF - 702 KB) |
Statistical (PDF -1 MB) |
PREA |
Barium sulfate - Varibar Pudding |
Bracco Diagnostics, Inc. |
Medical (PDF - 1MB) |
None |
None |
PREA |
Barium sulfate - Liquid E-Z-Paque |
Bracco Diagnostics, Inc. |
DD Summary Review (PDF - 233 KB) |
None |
None |
PREA |
Beclomethasone dipropionate - Qnasl |
Teva Branded Pharmaceutical Products R&D, Inc. |
Medical (PDF - 4 MB) |
Clinical pharmacology (PDF - 2 MB) |
Statistical (PDF -959 KB) |
PREA |
Belumosudil - Rezurock
|
Kadmon Pharmaceuticals, LLC |
Medical (PDF - 7MB) |
Non |
None |
PREA |
Belimumab - Benlysta |
Human Genome Sciences |
Medical (PDF - 6 MB) |
None |
None |
PREA |
Belimumab - Benlysta |
GlaxoSmithKline LLC |
Medical (PDF - 7 MB) |
None |
None |
PREA |
Benralizumab - Fasenra |
AstraZeneca AB |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 7 MB) |
Statistical (PDF - 2 MB) |
PREA |
Benralizumab - Fasenra |
AstraZeneca AB c/o AstraZeneca Pharmaceuticals LP |
Medical (PDF - 7 MB)
Unireview (PDF - 11 KB)
|
None |
None |
PREA |
Berdazimer - Zelsuvmi |
LNHC, Inc. |
Medical (PDF - 12 MB) |
None |
None |
PREA |
Bezlotoxumab - Zinplava |
Merck Sharp & Dohme Corp. |
Medical (PDF - 2 MB) |
None |
None |
BOTH |
Bictegravir, emtricitabine, and tenofovir alafenamide - Biktarvy |
Gilead Sciences, Inc. |
CDTL (PDF - 157 KB)
CDTL 1 (PDF - 2 MB)
|
Clinical pharmacology (PDF - 2 MB) |
None |
PREA |
Bictegravir, emtricitabine, and tenofovir alafenamide - Biktarvy |
Gilead Sciences, Inc. |
CDTL (PDF - 2 MB) |
Clinical pharmacology (PDF - 4 MB) |
None |
PREA |
Bimatoprost ophthalmic solution, 0.03% - Latisse |
Allergan, Inc. |
DD Summary Review (PDF - 966KB)
CDTL Review (PDF - 3 MB)
Medical (PDF - 2 MB)
|
None |
Statistical (PDF -946KB)
Statistical Addendum (PDF - 127KB)
|
PREA |
Blinatumomab - Blincyto
|
Amgen, Inc. |
Medical (PDF - 3 MB) |
Clinical pharmacology (PDF -1 MB) |
Statistical (PDF -374 KB) |
BPCA |
Blinatumomab - Blincyto |
Amgen, Inc. |
Medical (PDF - 9 MB) |
None
|
None |
BPCA |
Bortezomib - Velcade |
Millennium Pharmaceuticals, Inc. |
Medical (PDF - 4 MB) |
Clinical pharmacology (PDF -1 MB) |
Statistical (PDF - 374 KB) |
BPCA |
Bosutinib - BOSULIF |
PF Prism C.V |
Medical (PDF - 10 MB) |
None |
None |
BPCA |
Budesonide - Entocort EC |
Elan Pharma International |
Medical (PDF - 3 MB) |
Clinical pharmacology (PDF - 3 MB) |
Clinical pharmacology (PDF - 3 MB) |
PREA |
Brentuximab vedotin - Adcetris |
Seagen Inc. |
Medical (PDF - 1 MB) |
None |
None |
BPCA |
Brexanolone - Zulresso
|
Sage Therapeutics, Inc. |
Medical (PDF - 1 MB) |
None |
None |
PREA |
Brexpiprazole - Rexulti
|
Otsuka Pharmaceutical Company, Ltd. |
Medical (PDF - 4 MB) |
None |
None |
PREA |
Brimonidine tartrate - Lumify |
Bausch + Lomb |
CDTL Review (PDF - 3 MB)
Medical (PDF - 556 KB)
|
Clinical pharmacology (PDF - 51 KB) |
Statistical (PDF - 219 KB) |
PREA |
Brivaracetam - Briviact |
UCB, Inc. |
CDTL Review (PDF - 297 KB)
Medical (PDF - 1 MB)
|
Clinical pharmacology (PDF - 2 MB) |
None |
PREA
|
Brivaracetam - Briviact |
UCB, Inc. |
Medical (PDF - 74 KB) |
Clinical pharmacology (PDF - 2 MB) |
None |
PREA |
Budesonide/formoterol fumarate dehydrate - Symbicort |
AstraZeneca Pharmaceuticals, LP |
Medical (PDF - 3.4 MB) |
Clinical pharmacology (PDF - 1.2 MB) |
Statistical (PDF - 2.5 MB) |
BOTH |
Bupivacaine - Exparel |
Pacira Pharmaceuticals, Inc. |
Medical (PDF - 6 MB) |
Clinical pharmacology (PDF - 2 MB) |
None |
PREA |
Buprenorphine - Butrans |
Purdue Pharma L.P. |
Medical (PDF - 4.1 MB) |
Clinical pharmacology (PDF - 1.5 MB) |
None |
PREA |
Cabazitaxel - Jevtana |
Sanofi-Aventis U.S., L.L.C. |
Medical (PDF - 1.5 MB) |
Clinical pharmacology (PDF - 1.2 MB) |
None |
BPCA |
Cabotegravir - Apretude
|
ViiV Healthcare Company |
Medical (PDF - 8 MB) |
None |
None |
PREA |
Cabotegravir-rilpivirine - Cabenuva
|
ViiV Healthcare Company |
Medical (PDF - 35 KB) |
Clinical pharmacology (PDF - 1 MB)
Clinical pharmacology Addendum (PDF - 229 KB)
|
None |
PREA |
Cabotegravir - Vocabria |
ViiV Healthcare Company |
CDTL (PDF - 1 MB)
Medical (PDF - 525 KB)
|
Clinical pharmacology (PDF - 2 MB)
Addendum (PDF - 115 KB)
|
None |
PREA |
Calcipotriene - SORILUX Foam |
Mayne Pharma LLC |
Medical (PDF - 525 KB) |
None |
None |
PREA |
Calcipotriene - SORILUX |
Mayne Pharma LLC |
Medical (PDF - 525 KB) |
Clinical pharmacology (PDF - 1.2 MB) |
None |
PREA |
Calcipotriene and Betamethasone dipropionate - Taclonex |
LEO Pharma A/S |
Medical (PDF -5.6MB) |
Clinical pharmacology (PDF -2.4MB) |
Statistical (PDF -564 KB) |
PREA |
Calcipotriene and Betamethasone dipropionate - Taclonex |
LEO Pharma A/S c/o LEO Pharma, Inc. |
Medical (PDF - 3.7MB) |
Clinical pharmacology (PDF -2.7MB) |
None |
PREA |
Calcipotriene and Betamethasone dipropionate - Taclonex |
LEO Pharma A/S |
Medical (PDF - 775 KB) |
Clinical pharmacology (PDF - 528 KB) |
None |
PREA |
Calcipotriene and betamethasone - Enstilar |
LEO Pharma A/S |
Medical (PDF - 775 KB) |
N |
None |
BOTH |
Calcium Gluconate injection - Calcium Gluconate Injection |
Fresenius Kabi USA, LLC |
Medical (PDF - 4 MB)
Medical CTDL (PDF - 1.5 MB)
|
Clinical pharmacology (PDF - 1 MB) |
None |
PREA |
Calcitriol - Vectical
|
Galderma Laboratories, L.P. |
Medical (PDF - 3 MB) |
Clinical pharmacology (PDF - 1 MB) |
None |
PREA |
Cantharidin - Ycanth |
Verrica Pharmaceuticals Inc. |
Medical (PDF - 3 MB) |
None |
None |
PREA |
Capecitabine - Xeloda |
Hoffmann-La Roche, Inc. |
Medical (PDF - 4MB) |
Clinical pharmacology (PDF - 1MB) |
Statistical (PDF -610 KB) |
BPCA |
Carbinoxamine maleate - Karbinal ER |
Tris Pharma, Inc. |
Medical (PDF - 1.4MB) |
Clinical pharmacology (PDF - 500 KB) |
None |
PREA |
Cefazolin sodium and dextrose solution - Cefazolin for Injection USP and Dextrose Injection USP in the Duplex® Container |
B. Braun Medical Inc. |
Medical (PDF - 1 MB) |
None |
None |
PREA |
Ceftaroline fosamil - Teflaro |
Cerexa, Inc., A Subsidiary of Forest Laboratories, LLC |
Medical (PDF - 11 MB)
Medical CTDL (PDF - 2 MB)
|
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF -1 MB) |
PREA |
Ceftaroline fosamil - Teflaro |
Allergan Sales, LLC |
Medical (PDF - 5 MB) |
None |
None |
PREA |
Ceftazidime and Avibactam - Avycaz |
Allergan Sales, LLC |
Medical (PDF - 5 MB) |
None |
None |
PREA |
Ceftazidime and avibactam - Avycaz |
Allergan Sales, LLC |
Medical (PDF - 4 MB) |
None |
None |
PREA |
Ceftazidime and avibactam - Avyca |
AbbVie, Inc. |
Medical (PDF - 4 MB) |
None |
None |
PREA |
Ceftobiprole medocaril sodium for injection - Zevtera |
Basilea Pharmaceutica International, Ltd., Allschwil |
Medical (PDF - 4 MB) |
None |
None |
PREA |
Ceftolozane and tazobactam - Zerbaxa |
Cubist Pharmaceuticals, LLC |
Medical (PDF - 8 MB) |
None |
None |
PREA |
Certolizumab pegol - Cimzia |
UCB, Inc |
Medical (PDF - 4 MB) |
None |
None |
PREA |
Cetirizine ophthalmic solution - Zerviate |
Nicox Ophthalmics, Inc. |
Medical Resubmission (PDF - 231 KB)
Medical (PDF - 5 MB)
|
Clinical pharmacology (PDF - 279 KB) |
Statistical (PDF - 580 KB) |
BOTH |
Cetirizine hydrochloride - Quzyttir |
JDP Therapeutics Inc |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Ciclesonide - Zetonna |
Takeda GmbH |
Medical (PDF - 5 MB)
|
Clinical pharmacology (PDF -1 MB) |
Statistical (PDF -674 KB) |
PREA |
Cinacalcet hydrochloride - Sensipar |
|
CDTL (PDF - 2.2 MB)
Medical (PDF - 4.1 MB)
|
Clinical pharmacology (PDF - 5.6 MB) |
Statistical (PDF - 957 KB) |
BOTH |
Ciprofloxacin 0.3% and Fluocinolone acetonide 0.025% - Otovel Otic Solution |
Laboratorios SALVAT, S.A. |
Medical (PDF - 4MB) |
Clinical pharmacology (PDF -632 KB) |
Statistical (PDF -2MB) |
PREA |
Ciprofloxacin otic suspension - Otiprio |
Otonomy, Inc. |
Medical (PDF - 233 KB) |
Clinical pharmacology (PDF - 79 KB) |
Statistical (PDF - 213 MB |
PREA |
6% Ciprofloxacin Otic Suspension - Otiprio |
Otonomy, Inc. |
Medical (PDF - 2.3MB) |
Clinical pharmacology (PDF - 97 KB) |
Statistical (PDF -896 KB)
Addendum (PDF -157 KB
|
PREA |
Ciprofloxacin ophthalmic solution - Ciloxan |
Novartis Pharmaceuticals Corporation |
Medical (PDF - 110 KB)
Medical (PDF - 173 KB)
|
None |
None |
BPCA |
Clascoterone - Winlevi
|
Cassiopea SpA |
Medical (PDF - 3 MB) |
None |
None |
PREA |
Clindamycin phosphate, adapalene, and benzoyl peroxid - Cabtreo
|
Bausch Health US, LLC |
Medical (PDF - 4 MB) |
None |
None |
PREA |
Clindamycin phosphate - Xaciato |
Daré Bioscience Inc. |
Medical (PDF - 3 MB) |
None |
None |
PREA |
Clonidine - Kapvay |
Concordia Pharms Inc. |
Medical (PDF - 3 MB) |
None |
Statistical (PDF -2MB) |
PREA |
Cobicistat - Tybost |
Gilead Sciences, Inc. |
CDTL (PDF - 1 MB) |
Clinical pharmacology (PDF - 1 MB) |
None |
BOTH |
Cobimetinib - Cotellic
|
Genentech, Inc. |
Medical (PDF - 27 KB) |
Clinical pharmacology (PDF - 543 KB) |
None |
BPCA |
Colesevelam HCl - Welchol |
Daiichi Sankyo Inc. |
CDTL (PDF - 2 MB)
Medical (PDF - 12MB)
|
Clinical pharmacology (PDF - 7 MB) |
None |
PREA |
Colesevelam HCl - Welchol |
Daiichi Sankyo Inc. |
Medical (PDF - 3 MB) |
None |
Statistical (PDF - 308 KB) |
PREA |
Crisaborole Ointment, 2% - Eucrisa |
Anacor Pharmaceuticals Inc. |
CDTL Review (PDF - 2MB)
Medical (PDF - 12MB)
|
Clinical pharmacology (PDF - 7MB) |
Statistical (PDF - 1MB) |
PREA |
Crisaborole - Eucrisa |
Anacor Pharmaceuticals, LLC. |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Crisaborole - Eucrisa |
Pfizer |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 1 MB) |
None |
BPCA |
Cysteamine bitartrate - Procysbi |
Raptor Pharmaceuticals, Inc. |
Medical (PDF -12MB) |
Clinical pharmacology (PDF - 2 MB)
Clinical pharmacology addendum (PDF - 420 KB)
|
None |
BPCA |
Cysteamine bitartrate - Procysbi |
Horizon Pharma USA, Inc.
|
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF - 1 MB) |
BPCA |
Cysteamine hydrochloriden - CYSTADROPS |
Recordati Rare Diseases Inc. |
Medical (PDF - 294 KB) |
None |
None |
PREA |
Dabigatran etexilate - Pradaxa
|
Boehringer Ingelheim Pharmaceuticals, Inc. |
Medical (PDF - 2 MB)
Medical (PDF - 700 KB)
|
Clinical pharmacology (PDF - 5 MB) |
None |
BOTH |
Dabrafenib - Tafinlar |
Novartis Pharmaceuticals Corporation |
Medical (PDF - 18 MB) |
None |
None |
PREA |
Dabrafenib - Tafinlar |
Novartis Pharmaceuticals Corporation |
Medical (PDF - 10 MB)
CDTL (PDF - 1 MB)
|
Clinical pharmacology (PDF - 579 KB) |
None |
BPCA |
Dalbavancin hydrochloride - Dalvance
|
Allergan Sales, LLC |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Dalteparin sodium - Fragmin |
Pharmacia & Upjohn, a subsidiary of Pfizer Inc. |
Medical (PDF - 3.5 MB) |
None |
None |
PREA |
Darunavir, cobicistat, emtricitabine, and tenofovir alafenamide - Symtuza |
Jannsen |
Medical (PDF - 3.5 MB) |
Clinical pharmacology (PDF - 1.2MB) |
None |
PREA |
Dapsone - Aczone |
Allergan, Inc. |
Medical (PDF - 3.5 MB) |
Clinical pharmacology (PDF - 2.6 MB) |
Statistical (PDF -1.3 MB) |
PREA |
Dapsone - Aczone |
Almirall, LLC |
Medical (PDF - 3.5 MB) |
Clinical pharmacology (PDF - 2.6 MB) |
None |
PREA |
Daptomycin - Cubicin |
Cubist Pharmaceuticals, LLC c/o Merck Sharp & Dohme Corp. |
Medical (PDF - 505 KB) |
Clinical pharmacology (PDF - 1.8 MB)
|
Statistical (PDF -1.9 KB)
Statistical Addendum (PDF - 96 KB)
|
PREA |
Daptomycin - Cubicin |
Cubist Pharmaceuticals, LLC c/o Merck Sharp & Dohme Corp. |
Medical (PDF - 389 KB) |
Clinical pharmacology (PDF - 991 KB)
Clinical pharmacology Addendum (PDF - 80 KB)
|
Statistical (PDF - 374 KB)
|
PREA |
Daptomycin - Dapzura RT
|
Baxter Healthcare Corporation |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Darbepoetin alfa - Aranesp |
Amgen Inc. |
Medical (PDF - 2 MB) |
None |
Statistical (PDF -280KB) |
BPCA |
Darunavir and Cobicistat - Prezcobix |
Janssen Products, LP |
Medical (PDF - 147 KB) |
Clinical pharmacology (PDF - 20 KB) |
None |
PREA |
Darunavir - Prezista |
Janssen Products, L.P. |
Medical (PDF -1MB) |
Clinical pharmacology (PDF -1MB) |
None |
PREA |
Darunavir - Prezista |
Janssen Products, L.P. |
None |
Clinical pharmacology (PDF -352KB) |
None |
PREA |
Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide - Symtuza |
Janssen Products, L.P. |
Multi-disciplinary review (PDF - 8 MB) |
None |
None |
PREA |
Dasatinib - Sprycel
|
Bristol-Myers Squibb Company
|
CDTL Review (PDF - 1 MB)
Medical (PDF- 8 MB)
|
Clinical pharmacology (PDF - 531 KB)
|
Statistical (PDF - 19 KB) |
BPCA |
Dasiglucagon - Zegalogue |
Zealand Pharma A/S |
Medical (PDF - 5MB) |
Clinical pharmacology (PDF - 33KB)
Clinical pharmacology Addendum (PDF - 38KB)
|
Statistical (PDF - 2MB) |
PREA |
Daunorubicin and cytarabine (liposome injection) - Vyxeos |
Jazz Pharmaceuticals |
Multidisciplinary (PDF - 5 MB) |
None |
None |
BPCA |
Decitabine - Dacogen |
Eisai Inc. |
Medical (PDF -2 MB) |
Clinical pharmacology (PDF -1MB) |
None |
BPCA |
Deferasirox - Exjade |
Novartis Pharmaceuticals Corporation |
Medical (PDF - 9 MB) |
Clinical pharmacology (PDF - 1.5MB) |
Statistical (PDF - 2MB) |
BPCA |
Deferasirox - Exjade |
Novartis Pharmaceuticals Corporation |
CDTL Review (PDF - 795 KB)
Medical (PDF - 843 KB)
|
None |
None |
BPCA |
Deferasirox - Jadenu |
Novartis Pharmaceuticals Corporation |
CDTL Review (PDF - 2MB)
Medical (PDF - 1 MB)
|
Clinical pharmacology (PDF - 1MB) |
None |
BPCA |
Desoximetasone - Topicort |
Taro Pharmaceuticals U.S.A., Inc. |
Medical (PDF - 221 KB) |
Clinical pharmacology (PDF - 302 KB) |
None |
PREA |
Desvenlafaxine - Pristiq |
Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
Medical (PDF - 103 KB)
Medical (PDF - 622 KB)
|
Clinical pharmacology (PDF - 1.5 MB) |
Statistical (PDF - 1.5 MB) |
PREA |
Deutetrabenazine - Austedo
|
Teva Branded Pharmaceutical Products R&D, Inc. |
Medical (PDF - 622 KB) |
None |
None |
BPCA |
Dexlansoprazole - Dexilant |
Takeda Pharmaceuticals USA Inc. |
CDTL Review (PDF-661 KB)
Medical (PDF-5 MB)
|
Clinical pharmacology (PDF-1MB) |
Statistical (PDF-50KB) |
PREA |
Dexmedtomidine hydrochloride - Precedex |
Hospira |
Medical (PDF -5MB) |
Clinical pharmacology (PDF -3.8MB) |
Statistical (PDF -1MB) |
BPCA |
Dexmedetomidine - Precedex |
Hospira, Inc. |
CDTL Review (PDF - 3 MB) |
Clinical pharmacology (PDF -3.8MB) |
Statistical (PDF - 1MB) |
PREA |
Dextroamphetamine - Xelstrym |
Noven Pharmaceuticals, Inc. |
Medical (PDF - 1 MB) |
None |
None |
PREA |
Diclofenac epolamine topical system 1.3% - Flector
|
IBSA Institut Biochimique SA
|
Medical (PDF - 1 MB)
|
None |
None |
PREA |
Diclofenac potassium - Zipsor
|
Assertio Therapeutics, Inc. |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 453 KB) |
None |
PREA |
Difluprednate ophthalmic emulsion - Durezol |
Alcon Pharmaceuticals Ltd. c/o Alcon Research Ltd |
Medical (PDF -748 KB) |
Clinical pharmacology (PDF - 40KB) |
Statistical (PDF - 479KB) |
BPCA |
Dolutegravir and lamivudine - Dovato |
ViiV Healthcare Company |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Dolutegravir - Tivicay |
ViiV Healthcare |
Medical (PDF - 8MB) |
Clinical pharmacology (PDF -11 MB) |
Statistical (PDF -4MB) |
PREA |
Dolutegravir - Tivicay |
ViiV Healthcare |
Medical (PDF - 2 MB)
CDTL Review (PDF - 932 KB)
|
Clinical pharmacology (PDF -2.2MB) |
None |
PREA |
Dolutegravir - Tivicay PD |
ViiV Healthcare |
Medical (PDF - 241KB) |
Clinical pharmacology (PDF -89KB) |
None |
PREA |
Doravirine/lamivudine/tenofovir disoproxil fumarate - Delstrigo |
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. |
CDTL Review (PDF - 962 KB) |
Clinical pharmacology (PDF - 2 MB) |
None |
PREA |
Doxycycline hyclate delayed-release - Doryx |
Mayne Pharma International, Pty, Ltd. c/o Warner Chilcott US, LLC |
Medical (PDF - 241 KB) |
Clinical pharmacology (PDF - 89 KB) |
Statistical (PDF - 131 KB) |
PREA |
Doxycycline hyclate - LymePak |
Chartwell Pharma NDA B2 Holdings, LLC |
Medical (PDF - 1 MB) |
None |
None |
PREA |
Drospirenone and estetrol tablets - Nextstellis
|
Mayne Pharma LLC |
Medical (PDF - 3 MB) |
None |
None |
PREA |
Drospirenone - Slynd |
Exeltis USA, Inc |
Medical (PDF - 1 MB) |
None |
None |
PREA |
Dulaglutide - Trulicity |
Eli Lilly and Company |
CDTL (PDF - 1 MB) |
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 2 MB) |
BOTH |
Duloxetine - Cymbalta |
Eli Lilly and Company, Inc. |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF -197KB) |
Statistical (PDF - 3 MB) |
PREA |
Duloxetine - Cymbalta |
Eli Lily and Company, Inc. |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Duloxetine delayed-release capsules - Drizalma Sprinkle
|
Sun Pharma Global FZE |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Duloxetine hydrochloride - Cymbalta |
Eli Lilly and Company |
Medical (PDF - 8 MB) |
Clinical pharmacology (PDF - 959 KB) |
Statistical (PDF -665 KB) |
BPCA |
Dupilumab - Dupixent |
Regeneron Pharmaceuticals, Inc. |
Medical (PDF - 8 MB) |
None |
None |
PREA |
Dupilumab - Dupixent |
Regeneron Pharmaceuticals, Inc. |
Medical (PDF - 8 MB) |
None |
None |
PREA |
Dupilumab - Dupixent |
Regeneron Pharmaceuticals, Inc. |
Medical (PDF - 5 MB) |
None |
None |
PREA |
Dupilumab - Dupixent |
Regeneron Pharmaceuticals, Inc. |
Medical (PDF - 5 MB) |
None |
None |
PREA |
Dupilumab - Dupixent |
Regeneron Pharmaceuticals, Inc. |
Medical (PDF - 5 MB) |
None |
None |
PREA |
Econazole nitrate - Ecoza |
AmDerma Pharmaceuticals, LLC |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 422KB) |
PREA |
Edoxaban - Savaysa |
Daiichi Sankyo, Inc. |
CDTL (PDF - 4 MB)
Medical (PDF - 4 MB)
|
Clinical pharmacology (PDF - 1 MB) |
None |
PREA |
Efavirenz, lamivudine, tenofovir - Symfi Lo |
Mylan Pharmaceuticals, Inc. |
Medical (PDF - 129 KB) |
Clinical pharmacology (PDF - 1 MB) |
None |
PREA |
Efavirenz, lamivudine, tenofovir Disoproxil Fumarate - Symfi |
Mylan Pharmaceuticals, Inc. |
Medical (541 - KB) |
None |
None |
PREA |
Efavirenz, Lamivudine and Tenofovir disoproxil fumarate |
Aurobindo Pharma Limited, India |
DD Review (PDF - 65 KB) |
Clinical pharmacology (PDF - 788 KB) |
None |
PREA |
Efavirenz, lamivudine, tenofovir disoproxil fumarate
|
Macleods Pharmaceuticals Limited, India |
Medical (PDF - 1.9MB) |
Clinical pharmacology (PDF - 788 KB) |
None |
PREA |
Efavirenz - Sustiva |
Bristol-Myers Squibb Company |
Medical (PDF -1.9MB) |
Clinical pharmacology (PDF -9.3MB) |
None |
BOTH |
Efinaconazole - Jublia |
Bausch Health Americas, Inc.
|
Medical (PDF - 538 KB) |
None |
None |
PREA |
Elbasvir and grazoprevir - Zepatier
|
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 1 MB) |
None |
PREA |
Eltrombopag - Alvaiz |
Teva Pharmaceuticals Inc. |
CDTL (PDF - 2 MB)
Medical (PDF - 583 MB)
|
Clinical pharmacology (PDF - 975 MB) |
None |
PREA |
Eltrombopag - Promacta |
Novartis Pharmaceuticals Corporation |
Medical (PDF - 4 MB) |
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF -1MB) |
BPCA |
Eltrombopag - Promacta |
Novartis Pharmaceuticals Corporation |
Medical (PDF - 58 KB) |
None |
None |
BPCA |
Eltrombopag - Promacta |
Novartis Pharmaceuticals Corporation |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 97 KB) |
BPCA |
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir alafenamide - Genvoya |
Gilead Sciences, Inc. |
Medical (PDF -13.4MB) |
Clinical pharmacology (PDF -24.2MB) |
Statistical (PDF -2.2MB) |
PREA |
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir alafenamide - Genvoya |
Gilead Sciences, Inc. |
Medical (PDF - 642 KB) |
Clinical pharmacology (PDF - 242 KB) |
None |
BOTH |
Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir alafenamide - Genvoya
|
Gilead Sciences, Inc. |
CDTL (PDF - 3 MB) |
Clinical pharmacology (PDF - 9 MB) |
None |
BOTH |
Elvitegravir, Cobicistat, Emtricitabine/Tenofovir Disoproxil Fumarate - Stribild |
Gilead Sciences, Inc. |
CTDL Review (PDF -359KB) |
Clinical pharmacology (PDF - 462KB) |
None |
PREA |
Empagliflozin - Jardiance |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Medical - CDTL (PDF - 7 MB) |
Clinical pharmacology (PDF - 4 MB) |
Statistical (PDF - 2 MB) |
BPCA |
Empagliflozin and Metformin - Synjardy |
Boehringer Ingelheim Pharmaceuticals, Inc. |
CDTL (PDF - 7 MB) |
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 3 MB) |
BPCA |
Empagliflozin and Metformin - Synjardy XR |
Boehringer Ingelheim Pharmaceuticals, Inc. |
CDTL (PDF - 7 MB) |
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 3 MB) |
BPCA |
Emtricitabine, Rilpivirine, and Tenofovir alafenamide - Odefsey |
Gilead Sciences, Inc. |
Medical (PDF - 310KB)
CTDL Review (PDF - 578KB)
|
Clinical pharmacology (PDF - 5MB)
Clinical pharmacology addendum (PDF - 297 KB)
|
None |
PREA |
Emtricitabine, Rilpivirine, and Tenofovir alafenamide - Descovy |
Gilead Sciences, Inc. |
Medical (PDF - 1 MB)
Addendum (PDF - 572KB)
|
Clinical pharmacology (PDF -8 MB) |
Statistical (PDF -2 MB) |
PREA |
Emtricitabine, Rilpivirine, and Tenofovir alafenamide - Descovy |
Gilead Sciences, Inc. |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 8 MB) |
Statistical (PDF - 2 MB) |
PREA |
Emtricitabine and tenofovir alafenamide - Descovy |
Gilead Sciences, Inc. |
Medical (PDF - 642 KB) |
Clinical pharmacology (PDF -145 KB) |
None |
PREA |
Emtricitabine and tenofovir alafenamide - Descovy |
Gilead Sciences, Inc. |
CDTL Review (PDF - 2 MB) |
None |
None |
PREA |
Emtricitabine, Rilpivirine, and Tenofovir isoproxil fumarate - Complera |
Gilead Sciences, Inc. |
Medical (PDF - 1MB) |
Clinical pharmacology (PDF -145 KB) |
None |
PREA |
Emtricitabine and Tenofovir disoproxil fumarate - Truvada |
Gilead Sciences, Inc. |
Medical (PDF - 501KB) |
Clinical pharmacology (PDF -189KB) |
None |
PREA |
Entecavir - Baraclude |
Bristol-Myers Squibb Company |
Medical (PDF - 3 MB) |
Clinical pharmacology (PDF - 3MB) |
Statistical (PDF -660 KB) |
BOTH |
Entrectinib - Rozlytrek |
Genentech |
Medical (PDF - 23 MB) |
None |
None |
BPCA |
Entrectinib - Rozlytrek |
Genentech, Inc. |
Medical (PDF - 14 MB) |
None |
None |
BPCA |
Erlotinib - Tarceva |
OSI Pharmaceuticals, LLC |
Medical (PDF - 6 MB) |
Clinical pharmacology (PDF -2 MB) |
None |
BPCA |
Eribulin mesylate - Halaven |
Eisai Inc. |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 2 MB) |
None |
BPCA |
Epinephrine - Auvi-Q |
Kaleo, Inc. |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Epinephrine - Primatene Mist |
Armstrong Pharmaceuticals, Inc. |
CDTL Review (PDF - 2 MB)
Medical (PDF - 4 MB)
|
None |
Statistical (PDF - 660 KB) |
PREA |
Escitalopram oxalate - Lexapro |
Forest Laboratories, Inc. |
Medical (PDF - 218 KB) |
None |
None |
PREA |
Escitalopram - Lexapro |
AbbVie Inc. |
Medical (PDF - 6 MB) |
None |
None |
PREA |
Eslicarbazepine acetate - Aptiom |
Sunovion Pharmaceutical Inc. |
CDTL Review (PDF - 593 KB)
Medical (PDF - 5 MB)
|
Clinical pharmacology (PDF - 2.9 KB) |
None |
PREA |
Eszopiclone - Lunesta |
Sunovion Pharmaceuticals, Inc. |
Medical (PDF - 1MB) |
Clinical pharmacology (PDF -883KB) |
None |
BOTH |
Etafilcon - Theravision with Ketotifen |
Johnson & Johnson Vision Care, Inc. |
DD Review (PDF - 2 MB)
Medical (PDF - 460 KB)
|
None |
Statistical (PDF - 3 MB) |
PREA |
Etanercept - Enbrel |
Immunex Corporation, a wholly-owned subsidiary of Amgen Inc. |
Medical (PDF - 4.8 MB)
DD Review (PDF - 568 KB)
CDTL Review PDF - 504 KB)
|
Clinical pharmacology (PDF - 702 KB) |
Statistical (PDF - 444 KB) |
PREA |
Etanercept - Enbrel |
Amgen Inc. |
Medical (PDF - 4 MB) |
None |
None |
PREA |
Etanercept-szzs - Erelzi |
Sandoz Inc. |
Medical (PDF - 1.7 MB) |
Clinical pharmacology (PDF - 4.7 MB) |
Statistical (PDF - 432 KB) |
PREA |
Etanercept-szzs - Erelzi
|
Sandoz Inc. |
CDTL Review PDF - 504 KB)
|
None |
None |
PREA |
Etanercept-szzs - Erelzi
|
Sandoz Inc. |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Etravirine - Intelence |
Janssen Products, LP |
Medical (PDF -1.4MB) |
Clinical pharmacology (PDF -1.7MB) |
None |
BOTH |
Etravirine - Intelence |
Janssen Products, LP |
Medical (PDF -1 MB) |
Clinical pharmacology (PDF - 896 KB) |
None |
BOTH |
Everolimus tablets for oral suspension - Afinitor Disperz |
Novartis Pharmaceuticals Corporation |
Medical (PDF -10MB) |
Clinical pharmacology (PDF -2MB) |
None |
BPCA |
Evolocumab - Repatha |
Amgen, Inc. |
Medical (PDF - 5 MB) |
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF - 1 MB) |
PREA |
Exenatide - Bydureon |
AstraZeneca Pharmaceuticals AB C/O AstraZeneca Pharmaceuticals LP |
Medical (PDF - 3 MB) |
Clinical pharmacology (PDF - 2 MB) |
Statistical (PDF - 1 MB) |
BOTH |
Exenatide - Byetta |
AstraZeneca AB |
Medical (PDF - 802 KB) |
Clinical pharmacology (PDF - 14 KB) |
Statistical (PDF - 122 KB) |
BOTH |
Fenfluramine HCl - Fintepla
|
Zogenix, Inc. |
Medical (PDF - 588 KB) |
Clinical pharmacology (PDF - 2 MB) |
None |
BPCA |
Ferric oxyhydroxide - Velphoro |
Vifor Fresenius Medical Care Renal Pharma France |
Medical (PDF - 1 MB) |
None |
None |
BPCA |
Ferric carboxymaltose -Injectafer |
American Regent, Inc. |
Medical (PDF - 613 KB) |
Clinical pharmacology (PDF - 7 MB) |
None |
PREA |
Fesoterodine fumarate - Toviaz |
Pfizer, Inc.
|
Medical (PDF - 4 MB) |
Clinical pharmacology (PDF - 6 MB) |
Statistical (PDF - 300 KB) |
PREA |
Fidaxomicin - Dificid
|
Cubist Pharmaceuticals LLC |
Medical (PDF -3.8MB) |
None |
None |
BPCA |
Filgrastim-sndz - Zarxio |
Sandoz, Inc. |
Medical (PDF -3.8MB)
DD Review (PDF -86KB)
TL Review (PDF -422KB)
|
Clinical pharmacology (PDF -2.75MB)
Addendum (PDF - 1.1MB)
|
Statistical (PDF -6742KB) |
PREA |
Filgrastim-aafi - Nivestym |
Hospira, Inc. |
CDTL Review (PDF - 746 KB)
Medical (PDF - 245 KB)
|
Clinical pharmacology (PDF - 661 KB) |
Statistical (PDF - 377 KB) |
PREA |
Finafloxacin otic suspension - Xtoro |
Alcon Research, Ltd. |
Medical (PDF -6.8MB) |
Clinical pharmacology (PDF -2MB) |
Statistical (PDF -3.2MB) |
BOTH |
Fingolimod - Gilenya |
Novartis Pharmaceuticals Corporation |
CDTL Review (PDF - 2 MB)
Medical (PDF - 3.8 MB)
|
Clinical pharmacology (PDF -2MB) |
Statistical (PDF -3.2MB) |
BOTH |
Fingolimod - Tascenso ODT |
Handa Neuroscience, LLC
|
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 1 MB) |
None |
PREA |
Fluticasone furoate inhalation powder - Arnuity Ellipta |
GlaxoSmithKline |
Medical (PDF -8.6MB) |
Clinical pharmacology (PDF -5.7MB) |
Statistical (PDF -1.9) |
PREA |
Fluticasone furoate - Arnuity Ellipta |
GlaxoSmithKline |
Medical (PDF - 956 KB) |
Clinical pharmacology (PDF - 2 MB) |
Statistical (PDF - 507 KB) |
PREA |
Fluticasone furoate - Arnuity Ellipta |
GlaxoSmithKline Intellectual Property Development Ltd. England |
Medical (PDF - 956 KB) |
None |
None |
PREA |
Fluticasone furoate - Flonase Sensimist Allergy Relief |
Haleon US Holdings |
Medical (PDF - 489 KB) |
None |
Statistical (PDF - 133 KB) |
PREA |
Fluticasone Furoate/Umeclidinium/Vilanterol - Trelegy Ellipta |
GlaxoSmithKline Intellectual Property Development Ltd. England |
Medical (PDF - 3MB) |
None |
None |
PREA |
Fluticasone furoate/vilanterol - Breo Ellipta
|
GlaxoSmithKline |
Medical (PDF - 16 MB) |
Clinical pharmacology (PDF - 5 MB) |
Statistical (PDF - 4 MB) |
PREA |
Fluticasone furoate and vilanterol - Breo Ellipta |
GlaxoSmithKline Intellectual Property Development Ltd. England C/o GlaxoSmithKline Research & Development |
Medical (PDF - 6 MB) |
None |
None |
BPCA |
Fluticasone propionate Lotion - Cutivate |
Fougera Pharmaceuticals Inc. |
Medical (PDF -1.2MB) |
Clinical pharmacology (PDF -1.4MB) |
None |
PREA |
Fluticasone propionate/salmeterol xinafoate - Advair HFA |
GlaxoSmithKline |
Medical (PDF -1 MB) |
Clinical pharmacology (PDF -267KB) |
Statistical (PDF -52 KB) |
PREA |
Fluticasone propionate - ArmonAir RespiClick |
Teva Pharmaceutical Industries Ltd. |
Medical (PDF -10 MB) |
Clinical pharmacology (PDF - 4.3MB) |
Statistical (PDF -1.2 KB) |
PREA |
Fluticasone propionate - ArmonAir RespiClick
|
Teva Pharmaceutical Industries Ltd. c/o: Teva Branded Pharmaceutical Products R&D Inc. |
Medical (PDF - 6 MB) |
None |
None |
BOTH |
Fluticasone propionate/salmeterol - AirDuo |
Teva Pharmaceutical Industries Ltd. |
Medical (PDF -10 MB) |
Clinical pharmacology (PDF - 4.3 MB) |
Statistical (PDF -1.2 KB) |
PREA |
Formoterol fumarate and mometasone furoate - Dulera
|
Merck Sharp & Dohme Corp. |
Medical (PDF - 10 MB) |
None |
None |
BOTH |
Fosaprepitant - Emend |
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 7 MB) |
Statistical (PDF - 662 KB) |
BOTH |
Fosaprepitant - Focinvez
|
Spes Pharmaceuticals Inc.
|
Unireview (PDF - 248 MB)
Unireview (PDF - 1 MB)
|
None |
None |
PREA |
Fosphenytoin sodium - Cerebyx |
Parke-Davis, a Division of Pfizer, Inc. |
CDTL Review (PDF - 390 KB)
Medical (PDF - 1.5 MB)
|
Clinical pharmacology (PDF - 5 MB) |
None |
BPCA |
Gadobutrol - Gadavist |
Bayer HealthCare Pharmaceuticals, Inc. |
Medical (PDF - 958KB) |
Clinical pharmacology (PDF -2.2MB) |
Statistical (PDF -422 KB) |
PREA |
Gadobutrol - Gadavist |
Bayer Healthcare Pharmaceuticals, Inc. |
Medical (PDF - 7MB) |
None |
Statistical (PDF -782 KB) |
PREA |
Gadopiclenol - Elucirem
|
Guerbet LLC |
Medical (PDF - 3 MB) |
None |
None |
PREA |
Gadoterate meglumine - Dotarem |
Guerbet LLC |
Medical (PDF - 3MB) |
Clinical pharmacology (PDF -768KB) |
Statistical (PDF -1.2 MB) |
PREA |
Gadoterate meglumine - Dotarem |
Guerbet LLC |
Medical (PDF 1.3 MB) |
Clinical pharmacology (PDF - 1.5 MB) |
Statistical (PDF - 398 KB) |
PREA |
Gadoteridol - ProHance |
Bracco Diagnostics, Inc |
Medical (PDF - 3 MB) |
None |
None |
PREA |
Gadoxetate disodium - Eovist |
Bayer HealthCare Pharmaceuticals, Inc. |
Medical (PDF -1.2MB) |
Clinical pharmacology (PDF -1.5MB) |
None |
PREA |
Gatifloxacin ophthalmic solution - Zymar |
Allergan, Inc. |
Medical (PDF - 78 KB) |
None |
None |
BPCA |
Gatifloxacin - Zymar |
Allergan, Inc. |
DDTL (PDF - 428 KB) |
None |
None |
Both |
Gepirone - Exxua
|
Fabre-Kramer Pharmaceuticals, Inc. |
Medical (PDF - 10 MB) |
None |
None |
Both |
Glecaprevir and Pibrentasvir - Mavyret |
AbbVie Inc. |
CTDL (PDF - 2 MB)
CTDL Addendum (PDF - 187 KB)
|
Clinical pharmacology (PDF - 409 KB) |
Statistical (PDF - 439 KB) |
PREA |
Glecaprevir and Pibrentasvir - Mavyret |
AbbVie Inc. |
Medical (PDF - 78 KB) |
None |
None |
PREA |
Glecaprevir and pibrentasvir - Mavyret |
AbbVie, Inc. |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 3 MB) |
None |
BOTH |
Glucagon - Gvoke |
Xeris Pharmaceuticals, Inc. |
Medical (PDF - 3 MB)
CTDL Review (PDF - 3 MB
|
Clinical pharmacology (PDF - 2 MB) |
Statistical (PDF - 2 MB) |
PREA |
Glucagon - Baqsimi |
Eli Lilly and Company
|
Medical (PDF - 3 MB)
CTDL Review (PDF - 3 MB
|
Clinical pharmacology (PDF - 2 MB) |
Statistical (PDF - 2 MB) |
PREA |
Glycopyrronium - Qbrexza |
Dermira, Inc. |
Medical (PDF - 6 MB) |
None |
None |
PREA
|
Golimumab - Simponi |
Janssen Biotech, Inc. |
Medical (PDF - 3.1 MB)
|
Clinical pharmacology (PDF - 307 KB) |
Statistical (PDF - 1.1 MB) |
PREA |
Golimumab - Simponi Aria |
Janssen Biotech, Inc. |
Medical (PDF - 4 MB) |
None |
None |
PREA |
Guanfacine - Intuniv |
Shire |
Medical (PDF - 2 MB)
CTDL Review (PDF -134 KB)
|
Clinical pharmacology (PDF - 330 KB) |
Statistical (PDF - 544 KB) |
Both |
Guanfacine - Intuniv |
Shire |
Medical (PDF -3MB) |
Clinical pharmacology (PDF - 667KB) |
Statistical (PDF -3MB) |
PREA |
Halobetasol - Propionate Ultravate |
Sun Pharmaceutical Industries, Inc. |
Medical (PDF - 150 KB) |
Clinical pharmacology (PDF - 303 KB) |
None |
PREA |
Halobetasol Propionate - Lexette
|
Mayne Pharma LLC |
Medical (PDF - 249 KB) |
Clinical pharmacology (PDF - 752 KB) |
None |
BOTH |
Ibrexafungerp - Brexafemme |
SCYNEXIS, Inc. |
Medical (PDF - 10 MB) |
None |
None |
PREA |
Ibrexafungerp - Brexafemme |
SCYNEXIS, Inc. |
Medical (PDF - 1 MB) |
None |
None |
PREA |
Ibrutinib - Imbruvica |
Pharmacyclics LLC
|
Medical (PDF - 20 MB) |
None |
None |
BPCA |
Ibuprofen - Caldolor |
Cumberland Pharmaceuticals, Inc. |
CTDL Review (PDF -134 KB) |
Clinical pharmacology (PDF - 752 KB) |
None |
PREA |
Ibuprofen - Caldolor |
Cumberland Pharmaceuticals, Inc. |
DD Summary Review (PDF -669KB)
Medical (PDF -3MB)
|
Clinical pharmacology (PDF -3.7MB) |
Statistical (PDF -378KB) |
PREA |
IncobotulinumtoxinA - Xeomin |
Merz Pharmaceuticals GmbH |
Medical (PDF - 2 MB) |
None |
Statistical (PDF - 1 MB) |
PREA |
incobotulinumtoxinA - Xeomin |
Merz Pharmaceuticals GmbH |
Medical (PDF - 1 MB) |
None |
Statistical (PDF - 872 KB) |
PREA |
Indocyanine green for Injection - Spy Agent Green
|
Novadaq Technologies ULC |
Medical (PDF - 4 MB) |
None |
None |
PREA |
Infliximab-axxq - Avsola |
Amgen, Inc. |
Medical (PDF - 4 MB) |
None |
None |
PREA |
Infliximab-dyyb - Inflectra |
Celltrion, Inc. |
Medical (PDF -5.3MB)
Addendum (PDF - 1MB)
|
None |
Statistical (PDF -2MB) |
PREA |
Infliximab-abda - Renflexis |
Samsung Bioepsis Co., Ltd |
CDTL Review (PDF - 1 MB)
Medical (PDF - 3.5 MB)
Medical 2(PDF - 267 KB)
Medical 3 (PDF - 93 KB)
|
Clinical pharmacology (PDF - 7.7 MB) |
Statistical (PDF - 959 KB)
Statistical 2 (PDF - 602 KB)
|
PREA |
Insulin aspart injection - Fiasp |
Novo Nordisk Inc. |
CDTL Review (PDF - 1 MB)
Medical (PDF - 3.5 MB)
|
Clinical pharmacology (PDF - 4MB) |
Statistical (PDF - 905KB) |
PREA |
Insulin Degludec - Tresiba |
Novo Nordisk Inc. |
CDTL Review (PDF - 7MB)
Medical (PDF - 7 MB)
|
Clinical pharmacology (PDF - 4MB) |
Statistical (PDF - 905KB) |
PREA |
Insulin Degludec / Insulin Aspart) - Ryzodeg |
Novo Nordisk Inc. |
Medical (PDF - 7 MB) |
Clinical pharmacology (PDF - 4 MB) |
Statistical (PDF - 905 KB) |
PREA |
Insulin glargine-yfgn - Semglee
|
Mylan Pharmaceuticals Inc. |
Medical (PDF - 8 MB) |
None |
None |
PREA |
Insulin glargine-aglr - Rezvoglar |
Eli Lilly and Company |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Insulin lispro-aabc - Lyumjev
|
Eli Lilly and Company |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 10 MB)
Clinical pharmacology
addendum (PDF - 10 KB)
|
Statistical (PDF - 253 KB) |
PREA |
Iodixanol - Visipaque |
GE HealthCare Inc.
|
CDTL Review (PDF - 2 MB)
Medical (PDF - 2 MB)
|
Clinical pharmacology (PDF - 988 KB) |
Statistical (PDF - 1.8 MB) |
PREA |
Iohexol - Oraltag |
Interpharma Praha, a.s. |
Medical (PDF - 91 KB) |
Clinical pharmacology (PDF - 294 KB) |
Statistical (PDF - 98 KB) |
PREA |
Ipilimumab - Yervoy |
Bristol-Myers Squibb Company |
Medical (PDF 6 MB) |
Clinical pharmacology (PDF - 1.6 MB) |
None |
BPCA |
Iron Sucrose Injection, USP - Venofer |
Luitpold Pharmaceuticals, Inc. |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 114 KB) |
Statistical (PDF - 576 KB) |
PREA |
Isavuconazonium sulfate - Cresemba |
Astellas Pharma US Inc. |
Medical (PDF - 5 MB) |
None |
None |
BPCA |
Ivabradine - Corlanor |
Amgen Inc. |
CDTL (PDF - 3 MB)
Medical (PDF - 4 MB)
|
Clinical pharmacology (PDF - 4 MB) |
Statistical (PDF - 51 KB) |
BPCA |
Ivacaftor - Kalydeco |
Vertex Pharmaceuticals Incorporated |
Medical (PDF - 4 MB) |
None |
None |
BPCA |
Ixekizumab - Taltz |
Eli Lilly and Company |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Kit for the preparation of technetium Tc 99m-labeled carbon inhalation aerosol - Technegas |
Cyclomedica Australia Pty Ltd. |
Medical (PDF - 1 MB) |
None |
None |
PREA |
Kit for the Preparation of Technetium Tc 99m Pentetate Injection - Draximage |
Jubilant DraxImage, Inc
|
Medical (PDF - 2 MB) |
None |
Statistical (PDF - 1 MB) |
PREA |
Lacosamide - Motpoly XR |
Aucta Pharmaceuticals, Inc. |
Medical (PDF - 276 KB) |
Clinical pharmacology (PDF - 1 MB) |
None |
PREA |
Lacosamide - Vimpat |
UCB, Inc. |
CDTL Review (PDF - 371 KB)
Medical (PDF - 915 KB)
|
Clinical pharmacology (PDF - 2 MB) |
None |
PREA
|
Lacosamide - Vimpat |
UCB, Inc. |
Medical (PDF - 541 KB)
Medical (PDF - 631 KB)
|
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF - 2 MB) |
PREA |
Lacosamide - Vimpat |
UCB, Inc. |
Medical (PDF - 700 KB) |
Clinical pharmacology (PDF - 800 KB) |
None |
PREA |
Lacosamide - Vimpat |
UCB, Inc. |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF - 9 MB) |
PREA |
Lactic acid citric acid and K bitartrate - Phexxi |
Evofem, Inc. |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 1 KB) |
Statistical (PDF - 3 76706 KB) |
PREA |
Lamivudine - Epivir |
ViiV Healthcare Company |
Medical (PDF -4.2 MB) |
Clinical pharmacology (PDF - 3 MB) |
|
PREA |
Lamivudine and Raltegravir - Dutrebis |
Merck Sharp & Dohme Corp. |
Medical (PDF -1 MB) |
Clinical pharmacology (PDF - 6.4 MB) |
None |
PREA |
Lamivudine and tenofovir - Cimduo |
Mylan Pharmaceuticals India |
Medical (PDF - 73 KMB) |
Clinical pharmacology (PDF - 1 MB) |
None |
PREA |
Lamivudine and tenofovir disoproxil fumarate - Temixys
|
Celltrion, Inc. |
Medical (PDF - 20 KB)
|
Clinical pharmacology addendum (PDF - 166 KB)
Clinical pharmacology (PDF - 1 MB)
|
None |
PREA |
Lamotrigine - Lamictal |
GlaxoSmithKline LLC |
Medical (PDF -18 MB) |
Clinical pharmacology (PDF - 793 KB) |
Statistical (PDF - 1.8 MB) |
PREA |
Lanadelumab-flyo - Takhzyro |
Takeda Pharmaceuticals U.S.A., Inc. |
Medical (PDF - 7 MB) |
None |
None |
BPCA |
Ledipasvir-sofosbuvir - Harvoni |
Gilead Sciences, Inc. |
Medical and CDTL (PDF - 1.5 MB) |
Clinical pharmacology (PDF - 539 KB) |
Statistical (PDF - 205 KB) |
PREA |
Ledipasvir-sofosbuvir - Harvoni |
Gilead Sciences, Inc. |
Medical (PDF - 426 KB) |
None |
None |
BOTH |
Leuprolide acetate - Fensolvi |
Tolmar, Inc. |
Medical (PDF - 280 KB) |
Clinical pharmacology (PDF - 4 MB |
Statistical (PDF - 2 MB) |
PREA |
Levalbuterol hydrochloride - Xopenex |
Oak Pharmaceuticals |
Medical (PDF - 8 MB) |
Clinical pharmacology (PDF - 4 MB) |
Statistical (PDF - 2 MB) |
PREA |
Levalbuterol tartrate - Xopenex HFA |
Sunovion Pharmaceuticals Inc. |
Medical (PDF - 4 MB) |
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF 1 MB) |
PREA |
Levamlodipine - Conjupri |
CSPC Ouyi Pharmaceutical Co., Ltd. |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 569 KB) |
None |
PREA |
Levetiracetam - Keppra Extended Release Tablets |
UCB, Inc. |
DD Summary Review (PDF - 202 KB)
CDTL Review (PDF - 371 KB)
Medical (PDF - 327 KB)
|
Clinical pharmacology (PDF - 1 MB) |
None |
PREA |
Levomilnacipran - Fetzima |
AbbVie Inc. |
Medical (PDF - 4 MB) |
None |
None |
PREA |
Levonorgestrel - Liletta |
Medicines360 |
Medical (PDF - 9 MB) |
Clinical pharmacology (PDF - 1 MB)
Clinical pharmacology (PDF - 2 MB)
|
Statistical (PDF - 2 MB) |
PREA |
Levonorgestrel/ethinyl estradiol tablets |
Exeltis |
CDTL (PDF - 9 MB)
Medical (PDF - 9 MB)
Medical (PDF - 9 MB)
|
Clinical pharmacology (PDF - 1 MB)
Clinical pharmacology (PDF - 4 MB)
|
Statistical (PDF - 1.5 MB) |
PREA |
Levonorgestrel/ethinyl estradiol and ethinyl estradiol - Quartette |
Teva Branded Pharmaceutical Products R&D, Inc. |
Medical (PDF - 5 MB) |
Clinical pharmacology (PDF - 4 MB)
Clinical pharmacology addendum (PDF - 89KB)
|
Statistical (PDF - 1MB) |
PREA |
Levonorgestrel-releasing intrauterine system - Skyla |
Bayer HealthCare Pharmaceuticals, Inc. |
Medical (PDF - 8MB) |
Clinical pharmacology (PDF - 4MB) |
Statistical (PDF - 424 KB) |
PREA |
Levonorgestrel releasing intrauterine system - Liletta
|
Medicines360 |
CDTL Review (PDF - 179KB)
Medical (PDF - 2 MB)
|
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF - 168 KB) |
PREA |
Levonorgestrel - Mirena
|
Bayer HealthCare Pharmaceuticals, Inc. |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Levothyroxine sodium oral solution - Tirosint-SOL |
Cromsource, Inc. |
CDTL Review (PDF - 461 KB)
Medical (PDF - 3 MB)
|
Clinical pharmacology (PDF - 2 MB) |
None |
PREA |
Linaclotide - Linzess |
AbbVie Inc. |
Medical (PDF - 3 MB) |
None |
None |
BOTH |
Linagliptin and Metformin Hydrochloride - Jentadueto XR |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Medical (PDF - 7 MB) |
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF - 246 KB) |
BOTH |
Linagliptin and Metformin hydrochloride - Tradjenta |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Medical (PDF - 7 MB) |
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF - 246 KB) |
BOTH |
Linagliptin - Tradjenta |
Boehringer Ingelheim Pharmaceuticals, Inc |
Medical (PDF - 7 MB) |
Clinical pharmacology (PDF - 2 MB) |
Statistical (PDF - 2 MB) |
BOTH |
Lipid injectable emulsion - SMOFlipid |
Fresenius Kabi USA, LLC |
Medical (PDF - 3 MB) |
Clinical pharmacology (PDF - 2 MB) |
None |
PREA |
Liraglutide - Saxenda
|
Novo Nordisk, Inc. |
Medical (PDF - 5 MB) |
Clinical pharmacology (PDF - 5 MB) |
Statistical (PDF - 2 MB) |
PREA |
Liraglutide - Victoza |
Novo Nordisk Inc. |
Medical (PDF - 8 MB) |
Clinical pharmacology (PDF - 864 KB) |
Statistical (PDF - 450 KB) |
BOTH |
Lisdexamfetamine dimesylate - Vyvanse |
Shire Development, LLC |
Medical (PDF - 218 KB) |
Clinical pharmacology (PDF - 1 MB) |
None |
BOTH |
Lisdexamfetamine mesylate - Vyvanse |
Shire |
Medical (PDF - 2 MB) |
None |
Statistical (PDF - 1 MB) |
PREA |
Lisdexamfetamine dimesylate - Vyvanse
|
Takeda Pharmaceuticals U.S.A., Inc. |
Medical (PDF - 804 KB) |
None |
None |
BOTH |
Lisenatide - Adlyxin
|
Sanofi-aventis U.S. LLC |
Medical (PDF - 182 KB) |
Clinical pharmacology (PDF - 1 MB) |
None |
BOTH |
Lumacaftor and ivacaftor - Orkambi
|
Vertex Pharmaceuticals Incorporated |
Medical (PDF - 6 MB) |
None |
None |
BPCA |
Loteprednol - Lotemax |
Bausch & Lonb Inc. |
Medical (PDF - 318 KB)
Medical (PDF - 218 KB)
|
None |
Statistical (PDF - 3 MB) |
PREA |
Luliconazole - LuzuTM |
Medicis Pharmaceutical Corporation, a division of Valeant Pharmaceuticals NA LLC |
CDTL (PDF - 358 KB)
CDTL (PDF - 372 KB)
Medical (PDF - 306 KB)
Medical (PDF - 616 KB)
|
Clinical pharmacology (PDF -1 MB)
Clinical pharmacology (PDF - 423 KB)
|
Statistical (PDF - 207 KB) |
PREA |
Lopinavir / Ritonavir - Kaletra |
AbbVie Inc. |
Medical (PDF - 5.8 MB) |
Clinical pharmacology (PDF -2.3 MB) |
Statistical (PDF - 2 MB) |
PREA |
Lubiprostone - Amitizia |
Sucampo Pharmaceuticals Inc. |
Medical (PDF - 11 MB) |
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF - 1 MB) |
PREA |
Lutetium Lu177 dotatate - Lutathera |
Advanced Accelerator Applications USA, Inc. |
Medical (PDF - 3 MB) |
None |
None |
BPCA |
Lurasidone hydrochloride - Latuda |
Sunovion Pharmaceuticals, Inc. |
Medical (PDF - 6 MB)
Medical (PDF - 7 MB)
|
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 369 KB)
Statistical (PDF - 255 KB)
|
BOTH |
Lurasidone hydrochloride - Latuda |
Sunovion Pharmaceuticals, Inc. |
CDTL (PDF - 6 MB)
Medical (PDF - 6 MB)
|
Clinical pharmacology (PDF - 2 MB) |
Statistical (PDF - 368 KB) |
PREA |
Lurasidone hydrochloride - Latuda |
Sunovion Pharmaceuticals, Inc. |
Medical (PDF - 1 MB) |
None |
None |
PREA |
Maraviroc - Selzentry |
Viiv Healthcare |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 3 MB) |
None |
PREA |
Maraviroc - Selzentry |
Viiv Healthcare |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 3 MB) |
None |
BPCA |
Memantine hydrochloride - Namenda XR |
Forest Research Institute, Inc. (subsidiary of Forest Laboratories Inc.) |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 956 KB) |
Statistical (PDF - 1 MB) |
BPCA |
Mepolizumab - Nucala |
GlaxoSmithKline LLC |
Medical (PDF - 8 MB) |
Clinical pharmacology (PDF - 6 MB)
Clinical pharmacology addendum (PDF - 425 KB)
|
Statistical (PDF - 1 MB) |
PREA |
Mepolizumab - Nucala |
GlaxoSmithKline LLC |
Medical(PDF - 8 MB) |
None |
None |
PREA |
Mepolizumab - Nucala |
GlaxoSmithKline LLC |
Medical (PDF - 8 MB) |
None |
None |
PREA |
Mirabegron - Myrbetriq |
Astellas Pharma Global Development, Inc. |
Medical (PDF - 13 MB) |
Clinical pharmacology (PDF - 3 MB)
|
Statistical (PDF - 168KB) |
BOTH |
Mesalamine - Asacol HD |
Warner Chilcott |
Medical (PDF - 6 MB) |
Clinical pharmacology (PDF - 3 MB)
Clinical pharmacology (PDF - 518 KB)
|
Statistical (PDF -499 KB) |
PREA |
Mesalamine - Canasa |
Forest Laboratories |
Medical (PDF - 6 MB) |
Clinical pharmacology (PDF - 251 KB) |
Statistical (PDF - 344 KB) |
PREA |
Mesalamine - Delzicol |
Warner Chilcott LLC |
Medical (PDF - 707 KB)
Medical Addendum(PDF - 495 KB)
|
Clinical pharmacology (PDF - 116 KB) |
None |
PREA |
Mesalamine - Delzicol |
Warner Chilcott (US), LLC |
Medical (PDF - 5 MB) |
Clinical pharmacology (PDF - 729 KB) |
Statistical (PDF - 1 KB) |
PREA |
Mesalamine - Lialda |
Shire Development, LLC |
Medical (PDF - 6 MB) |
None |
None |
PREA |
Metformin hydrochloride for extended-release oral suspension - Riomet ER
|
Pharmaceutical Industries Limited |
CTDL Review (PDF - 917 KB) |
Clinical pharmacology (PDF - 818 KB) |
None |
PREA |
10% Methyl salicylate, 3% L-menthol - Salonpas Pain Relief |
Hisamitsu Pharmaceutical Co., Inc. |
Medical (PDF - 998 KB)
Medical (PDF - 3 MB)
|
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 1 MB) |
PREA |
Methylphenidate hydrochloride extended-release - Aptensio XR
|
Rhodes Pharmaceuticals L.P. |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 4 MB) |
Statistical (PDF - 1 MB)
Statistical (PDF - 629 KB) |
PREA |
Methylphenidate hydrochloride - Aptensio XR |
Rhodes Pharmaceuticals L.P. |
CTDL Review (PDF - 592 KB)
Medical (PDF - 3 MB)
|
Clinical pharmacology (PDF - 2 MB) |
Statistical (PDF - 1 MB)
Statistical (PDF - 139 KB)
|
BOTH |
Methylphenidate hydrochloride - Quillivant XR |
NextWave Pharmaceuticals, Inc. |
Medical (PDF - 26 KB) |
Clinical pharmacology (PDF - 588 KB) |
Statistical (PDF - 380 KB) |
PREA |
Methylphenidate hydrochloride extended release chewable tablets - QuilliChew ER |
Pfizer Inc. |
CTDL Review (PDF -1 MB)
Medical (PDF - 5 MB)
|
Clinical pharmacology (PDF -2.9MB) |
Statistical (PDF -498KB) |
PREA |
Methylphenidate HCL extended-release capsules - Adhansia XR
|
Purdue Pharma
|
Medical (PDF - 2 MB)
Medical (PDF - 5 MB)
|
Clinical pharmacology (PDF - 2 MB)
|
Statistical (PDF - 1 MB)
Statistical (PDF - 2 MB)
|
PREA |
Methylphenidate hydrochloride - Jornay PM
|
Ironshore Pharmaceuticals & Development, Inc. |
Medical (PDF - 4.8 MB) |
Clinical pharmacology (PDF - 2.1 MB) |
Statistical (PDF - 921 KB) |
PREA |
Methylphenidate extended-release orally disintegrating tablets - Cotempla XR-ODT |
Neos Therapeutics, Inc. |
Medical (PDF - 5.7 MB)
Medical (PDF - 1.2 MB)
|
Clinical pharmacology (PDF - 2.1 MB)
Clinical pharmacology (PDF - 2.1 MB)
|
Statistical (PDF - 921 KB)
Statistical (PDF - 96 KB)
|
PREA |
Methoxy polyethylene glycol-epoetin beta - Mircera |
Vifor International AG |
Medical (PDF - 2.3 MB)
|
None |
Statistical (PDF - 239 KB)
|
PREA |
Methoxy polyethylene glycol-epoetin beta - Mircera |
Vifor (International) AG c/o ProPharma Group |
Medical (PDF - 7 MB) |
Clinical Pharmacology (PDF - 5MB) |
Statistical (PDF - 7 MB) |
PREA |
Metoprolol Succinate - KAPSPARGO SPRINKLE |
Sun Sun Pharmaceutical Industries LimitedPharmaceutical Industries Limited |
Medical (PDF - 799 KB) |
Clinical pharmacology (PDF - 978 KB) |
None |
PREA |
Metronidazole - Likmez |
Saptalis Pharmaceuticals, LLC |
Medical (PDF - 6 MB) |
None |
None |
PREA |
Metronidazole vaginal gel 1.3% - Nuvessa |
Chemo Research SL |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 70 KB) |
Statistical (PDF - 127 KB) |
PREA |
Micafungin for injection - Mycamine |
Astellas Pharma US, Inc. |
Medical (PDF - 1 MB) |
None |
None |
BOTH |
Micafungin in Sodium Chloride Injection - Micafungi
|
Baxter HealthCare Corporation |
Medical (PDF - 1 MB) |
None |
None |
PREA |
Micafungin sodium - Mycamine |
Astellas Pharma US, Inc. |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 4.4MB)
|
Statistical (PDF -987KB) |
BPCA |
Minocycline - Amzeeq
|
Foamix Pharmaceuticals Inc. |
Medical (PDF - 2.2 MB) |
None |
None |
PREA |
Mirabegron extended-release tablets and mirabegron extended-release for oral suspension - Myrbetriq and Myrbetriq Granules |
Astellas Pharma Global Development, Inc. |
Medical (PDF - 13 MB) |
None |
None |
BOTH |
Mixed salts of a single-entity amphetamine product - Mydayis |
Shire Development, LLC. |
Medical (PDF - 7 MB)
|
Clinical pharmacology (PDF -1.8KB) |
Statistical (PDF -987KB) |
PREA |
Mixed salts of a single entity amphetamine product - Mydayis |
Shire Development, LLC. |
Medical (PDF - 7 MB) |
None |
None |
BPCA |
Mometasone furoate - Asmanex HFA |
Merck Sharp & Dohme Corp. |
Medical (PDF - 3 MB) |
Clinical pharmacology (PDF -2 MB) |
Statistical (PDF -603KB) |
PREA |
Mometasone furoate - Asmanex HFA |
Merck Sharp & Dohm Corp |
Medical (PDF- 1 MB) |
None |
None |
PREA |
Mometasone furoate - Asmanex HFA |
Merck Sharp & Dohm Corp |
Medical (PDF - 1 MB) |
None |
None |
PREA |
Mometasone furoate and formoterol fumarate - Dulera |
Schering-Plough |
Medical (PDF- 1 MB) |
None |
None |
PREA |
Morphine sulfate - Morphine sulfate |
Hospira, Inc. |
Medical (PDF - 1 MB) |
None |
None |
PREA |
Morphine sulfate - Morphine sulfate |
Hikma Pharmaceuticals USA Inc. |
Medical (PDF - 5 MB) |
Clinical pharmacology (PDF - 3 MB) |
None |
PREA |
Moxifloxacin - Avelox
|
Bayer Pharmaceuticals |
Medical (PDF- 905 KB) |
Clinical pharmacology (PDF - 2 MB) |
Statistical (PDF - 760 KB) |
PREA |
Moxifloxacin ophthalmic solution - Vigamox |
Alcon Pharmaceuticals, Ltd. |
Medical (PDF - 434 KB)
DD Summary Review (PDF- 118 KB)
|
None |
None |
BPCA |
Mycophenolate mofetil - CellCept
|
Roche Palo Alto LLC |
Medical (PDF - 6 MB) |
None |
None |
PREA |
Naftifine hydrochloride - Naftin |
Merz Pharmaceuticals, LLC |
Medical (PDF - 488 KB) |
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF - 188 KB) |
PREA |
Naftifine hydrochloride - Naftin Cream, 2% |
Merz Pharmaceuticals, LLC |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 2 MB) |
Statistical (PDF - 822 KB) |
PREA |
Nalmefene - Opvee |
Opiant Pharmaceuticals, Inc. |
CTDL Review (PDF - 4 MB)
|
Clinical pharmacology (PDF - 9 MB)
Clinical pharmacology addendum (PDF - 9 KB)
|
Statistical (PDF - 2 MB) |
PREA |
Naloxone hydrochloride - Kloxxado
|
Hikma Pharmaceuticals USA, Inc. |
CTDL Review (PDF - 613 KB)
CTDL and DD Review (PDF - 1 MB)
Medical (PDF - 4 MB)
|
None |
None |
PREA |
Naloxone hydrochloride - Narcan Nasal Spray |
Adapt Pharma Operations Limited |
DD Summary Review(PDF -1 MB)
CTDL Review (PDF - 3 MB)
|
Clinical pharmacology (PDF - 2 MB) |
None |
PREA |
Naloxone Hydrochloride Injection - Naloxone Hydrochloride Injection |
Kaleo, Inc. |
CDTL Review (PDF - 2 MB) |
Clinical pharmacology (PDF - 4 MB) |
None |
PREA |
Naloxone Hydrochloride - Rextovy |
Amphastar Pharmaceuticals, Inc |
Medical (PDF - 3 MB)
CDDD Review (PDF - 637 KB)
|
Clinical pharmacology (PDF - 2 MB) |
None |
PREA |
Naloxone Hydrochloride - Rezenopy |
Summit Biosciences |
Medical (PDF - 2MB)
CDTL Review (PDF - 3MB)
|
Clinical pharmacology (PDF - 1MB) |
None |
PREA |
Naloxone hydrochloride - RiVive |
Harm Reduction Therapeutics, Inc. |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Naloxone hydrochloride - Zimhi
|
Adamis Pharmaceuticals Corporation |
CDTL Review (PDF - 2 MB) |
Clinical pharmacology (PDF - 368 KB) |
None |
PREA |
Naproxen sodium 220 mg and Diphenhydramine hydrochloride - Aleve PM |
Bayer HealthCare, LLC – Consumer Care |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 2 MB) |
Statistical (PDF -1 MB) |
PREA |
Naproxen and esomeprazole magnesium - Vimovo |
Horizon Pharma Inc. |
Medical (PDF - 4 MB) |
Clinical pharmacology (PDF - 2 MB) |
None |
PREA |
Neostigmine methylsulfate - Bloxiverz |
Eclat Pharmaceuticals, LLC |
Medical (PDF - 8 MB) |
Clinical pharmacology (PDF - 2 MB) |
None |
PREA |
Neostigmine methylsulfate and glycopyrrolate - Prevduo |
Slayback Pharma LLC |
CDTL Review (PDF - 794 KB) |
Clinical pharmacology (PDF - 284 KB) |
None |
PREA |
Nevirapine - Viramune XR |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Medical (PDF -2MB) |
Clinical pharmacology (PDF - 446 KB) |
Statistical (PDF - 723KB) |
PREA |
Nilotinib - Tasigna |
Sponsor: Novartis Pharmaceuticals Corporation |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 1.6 MB) |
Statistical (PDF - 124 KB) |
BPCA |
Nintedanib - Ofev |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Medical (PDF - 10 MB) |
None |
None |
BPCA |
Nirmatrelvir - Ritonavir - Paxlovid |
Pfizer, Inc |
Medical (PDF - 27 MB) |
None |
None |
PREA |
Nirsevimab-alip - Beyfortus |
AstraZeneca AB |
Medical (PDF - 20 MB) |
None |
None |
PREA |
Nitisinone - NITYR |
Cycle Pharmaceuticals Ltd. |
Medical (PDF - 358 KB) |
Clinical pharmacology (PDF - 4 MB) |
None |
PREA |
Nitisinone - NITYR |
Cycle Pharmaceuticals Ltd. |
Medical (PDF - 358 KB) |
None |
None |
PREA |
Nivolumab - Opdivo
|
Bristol-Myers Squibb Company
|
DD (PDF - 188 KB)
Medical (PDF - 222 KB)
|
Clinical pharmacology (PDF - 202 KB)
Clinical pharmacology (PDF - 250 KB)
|
Noen |
PREA |
Nivolumab - Opdivo |
Bristol-Myers Squibb Company |
Medical (PDF - 8 MB) |
None |
None |
BPCA |
Nivolumab - Opdivo |
Bristol-Myers Squibb Company |
Medical (PDF - 11 MB) |
None |
None |
BPCA |
Nivolumab and relatlimab-rmbw - Opdualag
|
Bristol-Myers Squibb Company |
Medical (PDF - 29 MB) |
None |
None |
PREA |
Norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules - Taytulla |
Warner Chilcott Company, LLC |
Medical (PDF -1MB) |
Clinical pharmacology (PDF -3.2MB) |
Statistical (PDF - 469 KB) |
PREA |
Obiltoxaximab - Anthim |
Elusys Theraputics, Inc. |
Medical (PDF -18 MB)
Addendum (PDF - 249 KB)
|
Clinical pharmacology (PDF -12MB)
Addendum (PDF -126 KB)
|
Statistical (PDF - 9 MB) |
PREA |
Ocriplasmin- Jetrea |
ThromboGenics, Inc. |
Medical (PDF - 817 KB) |
Clinical pharmacology (PDF - 117KB) |
Statistical (PDF - 760 KB) |
PREA |
Olanzapine and fluoxetine hydrochloride - Symbyax |
Eli Lilly and Company |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF -1.2MB)
Addendum (PDF - 132KB)
|
Statistical (PDF - 953 KB) |
PREA |
Olopatadine - Pazeo |
Alcon Research LTD |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF -340KB) |
Statistical (PDF - 4 KB) |
BOTH |
Olopatadine hydrochloride and mometasone furoate - Ryaltris |
Glenmark Specialty SA |
Medical (PDF - 6 MB)
CDTL (PDF - 6 MB)
|
None |
None |
PREA |
Omalizumab - Xolair |
Genentech |
Medical (PDF - 6 MB) |
Clinical pharmacology (PDF -1.3MB) |
Statistical (PDF - 2MB) |
PREA |
Omalizumab - Xolair |
Genentech, Inc. and Novartis Pharmaceuticals Corp. |
Medical (PDF- 4 MB) |
Clinical pharmacology (PDF -1MB) |
Statistical (PDF - 1 MB) |
PREA |
Omalizumab - Xolair
|
Genentech, Inc. and Novartis Pharmaceuticals Corp. |
Medical (PDF - 5 MB) |
None |
None |
PREA |
Omalizumab - Xolair |
Genentech, Inc. |
Medical (PDF - 8 MB) |
None |
None |
PREA |
Omeprazole magnesium - Prilosec |
AstraZeneca Pharmaceuticals LP |
Medical (PDF - 908 KB) |
Clinical pharmacology (PDF - 2 MB) |
None |
PREA |
OnabotulinumtoxinA - Botox
|
Allergan, Inc. |
CDTL (PDF - 403 KB)
Medical (PDF - 1 MB)
|
None |
Statistical (PDF - 173 KB) |
PREA |
OnabotulinumtoxinA - Botox |
Allergen, Inc |
Medical (PDF - 3 MB)
Medical (PDF - 1 MB)
|
None |
Statistical (PDF - 1 MB) |
PREA |
OnabotulinumtoxinA - Botox |
Allergen, Inc |
Medical (PDF - 1 MB) |
None |
None |
PREA |
OnabotulinumtoxinA - Botox
|
Allergan, Inc. |
Medical (PDF - 1 MB) |
None |
Statistical (PDF - 2 MB) |
PREA |
OnabotulinumtoxinA - Botox
|
Allergan, Inc. |
Medical (PDF - 3 MB) |
None |
None |
PREA |
Oxaprozin - Coxanto |
Solubiomix, Inc. |
Medical (PDF - 3 MB) |
Clinical pharmacology (PDF - 2 MB) |
None |
PREA |
Oxcarbazepine - Oxtellar XR |
Supernus Pharmaceuticals, Inc. |
Medical (PDF - 5 MB) |
Clinical pharmacology (PDF - 7 MB) |
Statistical (PDF - 482 KB) |
PREA |
Oxycodone hydrochloride - Oxycodone hydrochloride |
Genus Lifesciences, Inc. |
Medical (PDF - 2 MB)
DD Memo (PDF - 1 MB)
|
Clinical pharmacology (PDF - 688 KB) |
None |
PREA |
Oxycodone hydrochloride - Oxycontin |
Purdue Pharma L.P. |
Medical (PDF - 17 MB) |
Clinical pharmacology (PDF - 2 MB) |
Statistical (PDF - 678 KB) |
BPCA |
Oxymorphone - Opana |
|
Medical (PDF - 17 MB) |
Clinical pharmacology (PDF - 2 MB) |
None |
PREA |
Ozenoxacin - Xepi |
Ferrer Internacional S.A. |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF - 524 KB) |
PREA |
Paclitaxel - Abraxane |
Abraxis BioScience, L.L.C., a wholly-owned subsidiary of Celgene Corporation |
Medical (PDF - 235 KB) |
None |
None |
BPCA |
Palifermin - Kepivance |
Quintiles, Inc. |
Medical (PDF - 280 KB) |
Clinical pharmacology (PDF - 726 KB) |
None |
PREA |
Palonosetron hydrochloride - Aloxi |
Helsinn Healthcare SA |
Medical (PDF - 15 MB)
Medical (PDF - 2 MB)
|
Clinical pharmacology (PDF -2 MB) |
Statistical (PDF - 771 KB) |
BOTH |
Pancrelipase - Creon |
AbbVie Inc. |
Medical (PDF - 566 KB) |
None |
None |
PREA |
Pancrelipase - Pancreaze |
Janssen Pharmaceuticals, Inc. |
Medical (PDF - 142 KB) |
None |
None |
PREA |
Pancrelipase - Pertzye |
Digestive Care, Inc. |
Medical (PDF - 1 MB) |
None |
None |
PREA |
Pancrelipase - Zenpep |
Aptalis Pharma Limited. |
Medical (PDF - 587 KB) |
None |
None |
PREA |
Paricalcitol - Zemplar |
AbbVie Inc. |
Medical (PDF - 3 MB)
CDTL (PDF - 1 MB)
|
Clinical pharmacology (PDF - 2 MB) |
Statistical (PDF - 427 KB) |
PREA |
Patiromer - Veltassa |
Vifor Pharma, Inc. |
Medical (PDF - 3 MB) |
None |
None |
PREA |
Pegfilgrastim-cbqv - UDENYCA
|
Coherus BioSciences, Inc
|
Medical (PDF - 184 KB)
Medical (PDF - 228 KB)
CDTL (PDF - 584 KB)
|
Clinical pharmacology (PDF - 968 KB) |
Statistical (PDF - 199 KB) |
PREA |
Pegfilgrastim-fpgk - Stimufend |
Fresenius Kabi USA, LLC |
CDTL (PDF - 198 KB) |
None |
None |
PREA |
Pegfilgrastim-bmez - Ziextenzo |
Sandoz Inc. |
CDTL (PDF - 348 KB) |
None |
None |
PREA |
Peginterferon alfa-2a - Pegays |
Hoffmann-La Roche, Incorporated |
Medical (PDF - 799 KB) |
Clinical pharmacology (PDF - 667 KB) |
Statistical (PDF - 667 KB) |
PREA |
Peramivir - Rapivab |
BioCryst Pharmaceuticals, Inc. |
Medical (PDF - 767 KB |
Clinical pharmacology (PDF -468 KB) |
Statistical (PDF - 767KB) |
PREA |
Peramivir - Rapivab
|
BioCryst Pharmaceuticals, Inc. |
Medical (PDF - 1 MB |
Clinical pharmacology (PDF - 81 KB) |
None |
PREA |
Perampanel - Fycompa |
Eisai, Inc. |
Medical (PDF - 5 MB) |
Clinical pharmacology (PDF -6MB) |
Statistical (PDF -1.2MB) |
PREA |
Perampanel - Fycompa |
Eisai, Inc. |
Medical (PDF - 3 MB)
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF -4MB) |
Statistical (PDF -1.3MB) |
PREA |
Perampanel - Fycompa |
Eisai Inc. |
Medical (PDF - 3 MB)
Medical MTL (PDF - 678 KB)
|
Clinical pharmacology (PDF -1.2MB) |
None |
PREA |
Perampanel - Fycompa |
Eisai Inc. |
Medical (PDF - 79 KB) |
Clinical pharmacology (PDF - 86 KB) |
None |
PREA |
Perampanel - Fycompa
|
Eisai Inc.
|
CDTL (PDF - 452 KB)
Medical (PDF - 5 MB)
|
Clinical pharmacology (PDF - 2.5 MB) |
None |
PREA |
Perflutren lipid microsphere - DEFINITY and DEFINITY RT
|
Lantheus Medical Imaging, Inc. |
Medical (PDF - 719 KB) |
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF - 858 KB) |
PREA |
Pentermine and topiramate - Qsymia
|
VIVUS LLC |
Medical (PDF - 9 MB) |
Clinical pharmacology (PDF - 587 KB) |
Statistical (PDF - 858 KB) |
PREA |
Phentolamine mesylate - OraVerse |
Septodont Holding Sas |
Medical (PDF - 3 MB) |
None |
Statistical (PDF - 1 MB) |
PREA |
Phenylephrine hydrochloride ophthalmic solution |
Paragon BioTeck, Inc. |
Medical (PDF - 1MB) |
Clinical pharmacology (PDF - 95 KB) |
Statistical (PDF -1 MB) |
PREA |
Phentolamine ophthalmic solution - Ryzumvi
|
Ocuphire Pharma, Inc. |
CDTL (PDF - 1 MB)
Medical (PDF - 1 MB)
|
Clinical pharmacology (PDF - 1 MB) |
None |
PREA |
Phenylephrine and ketorolac - Omidria |
Omeros Corporation |
CDTL (PDF - 1 MB)
Medical (PDF - 4 MB) |
None |
Statistical (PDF - 816 KB) |
BPCA |
Piperacillin and tazobactam - Zosyn |
Wyeth Pharmaceuticals LLC |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Pitavastatin - Livalo
|
Kowa Pharmaceuticals America, Inc. |
CDTL Review (PDF - 526 KB)
Medical (PDF - 2 MB)
|
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 240 KB) |
BPCA |
Pomalidomide - POMALYST |
Celgene Corporation |
Medical (PDF - 15 KB) |
Clinical pharmacology (PDF - 1 MB) |
None |
BPCA |
Posaconazole - Noxafil |
Merck Sharp & Dohme Corp. |
Medical (PDF - 3 MB) |
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF - 252KB) |
PREA |
Posaconazole - Noxafil |
Merck |
Medical (PDF - 602 KB) |
Clinical pharmacology (PDF - 645 KB) |
None |
PREA |
Posaconazole - Noxafil |
Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., Inc. |
Medical (PDF - 8 MB) |
None |
None |
PREA |
Potassium phosphate |
Fresenius Kabi USA, LLC |
Medical (PDF - 602 KB) |
None |
None |
PREA |
Potassium Phosphates - Potassium Phosphates NEW
|
CMP Development LLC |
Medical (PDF - 3 MB) |
None |
None |
PREA |
Prasugrel - Effient |
Eli Lilly and Company |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 911 KB) |
Statistical (PDF -290 KB) |
BPCA |
Pregabalin - Lyrica |
Pfizer |
Medical (PDF - 4 MB) |
Clinical pharmacology (PDF - 6 KB) |
Statistical (PDF - 825 KB) |
PREA |
Pregabalin - Lyrica |
PF PRISM CV |
Medical and Statistical (PDF - 1 MB) |
Clinical pharmacology (PDF - 1.3 MB) |
Medical and Statistical (PDF - 1 MB) |
PREA |
Pregabalin - Lyrica |
Pfizer |
CTDL Review (PDF - 1 MB)
Medical (PDF - 1 MB)
|
Clinical pharmacology(PDF -1 MB) |
Statistical (PDF - 2 MB) |
BOTH |
Quetiapine fumarate - Seroquel and Seroquel XR |
AstraZeneca Pharmaceuticals LP |
CTDL Review (PDF - 1 MB)
Medical (PDF - 3 MB)
|
Clinical pharmacology (PDF - 2 MB)
Clinical pharmacology (PDF - 739 KB)
|
Statistical (PDF - 785 KB) |
PREA |
Rabeprazole sodium - AcipHex Sprinkle |
Eisa Inc. |
Medical (PDF - 3 MB) |
Clinical pharmacology (PDF - 5 MB) |
Statistical (PDF 185 KB) |
BOTH |
Ramucirumab - Cyramza
|
Eli Lilly and Company |
Medical (PDF - 198 KB) |
Clinical pharmacology (PDF - 168 KB) |
None |
BPCA |
Raltegravir - Isentress |
Merck Sharp Dohme Corp |
Medical (PDF - 1MB) |
Clinical pharmacology (PDF - 2 MB) |
None |
PREA |
Raltegravir - Isentress |
Merck Sharp Dohme Corp |
CDTL Review (PDF - 5 MB) |
Clinical pharmacology (PDF - 5 MB) |
Statistical (PDF 874 KB) |
PREA |
Raltegravir - Isentress |
Merck Sharp Dohme Corp |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 1 MB) |
None |
BOTH |
Ravulizumab-cwvz - Ultomiris
|
Alexion Pharmaceuticals, Inc. |
Medical (PDF - 5 MB) |
None |
None |
PREA |
Remdesivir - Veklury |
Gilead Sciences, Inc.
|
Medical (PDF - 1 MB)
Medical (PDF - 776 KB)
|
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 225 KB)
Statistical (PDF - 782 KB)
|
PREA |
Remdesivir - Veklury
|
Gilead Sciences, Inc. |
CDTL (PDF - 3 MB) |
None |
None |
PREA |
Remdesivir - Veklury
|
Gilead Sciences, Inc. |
CDTL (PDF - 3 MB) |
None |
None |
PREA |
Remdesivir - Veklury |
Gilead Sciences, Inc. |
CDTL (PDF - 4 MB) |
None |
None |
BOTH |
Reslizumab - Cinqair |
Teva Respiratory, LLC |
Medical (PDF - 5 MB) |
Clinical pharmacology (PDF - 9 MB) |
Statistical (PDF - 2 MB) |
PREA |
Rifapentin - Priftin |
Sanofi US Services Inc. |
Medical (PDF - MB) |
Clinical pharmacology (PDF - 5 MB) |
Statistical (PDF - 3 MB) |
PREA |
Rilpivirine - Edurant |
Janssen Products L.P. |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF -138 KB) |
None |
PREA |
Rilpivirine - Edurant |
Janssen Products L.P. |
Medical (PDF - 41 MB) |
Clinical pharmacology (PDF - 2 MB)
Clinical pharmacology (PDF - 235 KB)
|
|
PREA |
Rilpivirine - Edurant |
Janssen Products, LP |
Medical (PDF - 9 MB) |
None |
None |
BPCA |
Rivaroxaban - Xarelto |
Janssen Pharmaceuticals, Inc. |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 10 MB) |
Statistical (PDF - 797 KB) |
BOTH |
Risperidone - Risperdal Consta |
Janssen Pharmaceuticals, Inc. |
DD Summary Review (PDF - 20 KB)
CTDL Review (PDF - 1MB)
Medical (PDF - 670KB)
Medical (PDF - 667 KB)
|
None |
Statistical (PDF - 237KB) |
PREA |
Ritlecitinib - Litfulo |
Pfizer, Inc. |
Medical (PDF - 15 MB) |
None |
None |
PREA |
Rituximab-arrx - Riabni
|
Amgen, Inc. |
Medical (PDF - 7 MB) |
None |
None |
PREA |
Rizatriptan - RizaFilm |
IntelGenx Corp. |
Medical (PDF - 352 KB)
Memo (PDF - 851 KB)
|
Clinical pharmacology (PDF - 220 KB) |
None |
PREA |
Roflumilast - Zoryeve |
Arcutis Biotherapeutics, Inc. |
Medical (PDF - 6 MB) |
None |
None |
PREA |
Roflumilast - Zoryeve
|
Arcutis Biotherapeutics, Inc. |
Medical (PDF - 5 MB) |
Clinical pharmacology (PDF - 3 MB) |
None |
PREA |
Roflumilast - Zoryeve |
Arcutis Biotherapeutics, Inc. |
Medical (PDF - 5 MB) |
None |
None |
PREA |
Rosuvastatin - Ezallor Sprinkle |
Sun Pharmaceutical Industries Limited |
Medical (PDF - 27 KB) |
None |
None |
PREA |
Rufinamide - Banzel |
Eisai Inc. |
Medical (PDF - 10 MB) |
Clinical pharmacology (PDF - 3MB) |
None |
BPCA |
Ruxolitinib - Jakafi |
Incyte Corporation
|
Medical (PDF - 685 KB) |
Clinical pharmacology (PDF - 533 KB) |
None |
BPCA |
Ruxolitinib - Jakafi |
Incyte Corporation |
Medical (PDF - 685 KB) |
None |
None |
BPCA |
Ruxolitinib - Opzelura
|
Incyte Corporation |
Medical (PDF - 9 MB) |
None |
None |
PREA |
Ruxolitinib - Opzelura |
Incyte Corporation |
Medical (PDF - 7 MB) |
None |
None |
PREA |
Sacubitril-valsartan - Entresto |
Novartis Pharmaceuticals Corp. |
Medical (PDF - 685 KB) |
Clinical pharmacology (PDF - 533 KB) |
Statistical (PDF -1MB) |
BPCA |
Sacubitril-valsartan - Entresto |
Novartis Pharmaceuticals Corp. |
CDTL (PDF - 727 KB)
Medical (PDF - 9 MB)
|
Clinical pharmacology (PDF - 6 MB) |
None |
PREA |
Sapropterin dihydrochloride - Kuvan |
BioMarin Pharmaceutical Inc. |
Medical (PDF - 4 MB) |
Clinical pharmacology (PDF -3 MB) |
None |
BPCA |
Saquinavir mesylate - Invirase |
Hoffmann La-Roche, Inc.orporated c/o Genentech, Inc. |
Medical (PDF -1 MB) |
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF -1MB) |
BOTH |
Sarecycline - Seysara
|
Allergan, Inc. |
Medical (PDF -1 MB) |
None |
None |
PREA |
Secnidazole - Solosec |
Lupin Pharmaceuticals, Inc. |
Medical (PDF 4 MB) |
None |
None |
PREA |
Secnidazole - Solosec |
Lupin Pharmaceuticals, Inc. (A subsidiary of Lupin Inc.) |
Medical (PDF 2 MB) |
None |
None |
PREA |
Secukinuma - Cosentyx
|
Novartis Pharmaceuticals Corporation |
Medical (PDF - 6 MB) |
None |
None |
PREA |
Selegiline - Emsam |
Somerset Pharmaceuticals |
Medical (PDF -1 MB)
Medical 2 (PDF -1 MB)
Medical Secondary 1 (PDF - 349 KB)
Medical Secondary 2 (PDF -188 KB)
|
None |
None |
PREA |
Selenious Acid - Selenious Acid |
American Regent, Inc. |
Medical (PDF - 8 MB) |
None |
None |
PREA |
Selenious Acid - Selenious Acid |
American Regent, Inc. |
Medical (PDF - 8 MB) |
None
|
None |
PREA |
Segesterone acetate and ethinyl estradiol vaginal systems - Annovera |
The Population Council, Inc. |
Medical (PDF - 5 MB) |
None |
None |
PREA |
Semaglutide - Wegovy |
Novo Nordisk Inc. |
Medical (PDF - 8 MB)
|
Clinical pharmacology (PDF - 16 MB) |
Statistical (PDF - 869 KB) |
PREA |
Serdexmethylphenidate and dexmethylphenidate - Azstarys |
Commave Therapeutics |
Multidisciplinary (PDF - 7 MB) |
None |
None |
PREA |
Sevelamer Carbonate - Renvela |
Genzyme/Sanofi |
Medical (PDF - 745 KB) |
Clinical pharmacology (PDF - 542 KB) |
Statistical (PDF - 541KB) |
PREA |
Sitagliptin - Januvia, Janumet & Janumet XR
|
Merck Sharp & Dohme Corp.: |
CDTL (PDF - 1 MB)
Medical (PDF - 4 MB)
|
Clinical pharmacology (PDF - 339 KB) |
Statistical (PDF - 623 KB) |
BOTH |
Sildenafil - Revatio |
Pfizer, Inc. |
Medical (PDF - 6 MB) |
Clinical pharmacology (PDF -2MB) |
Statistical (PDF - 508 KB) |
BOTH |
Sodium oxybate - Xyrem |
Jazz Pharmaceuticals
|
Medical (PDF - 193 KB) |
Clinical pharmacology (PDF - 2MB) |
Statistical (PDF - 508 KB) |
BPCA |
Sodium picosulfate, magnesium oxide, and anhydrous citric acid - Prepopik |
Ferring Pharmaceuticals Inc. |
Medical (PDF - 193 KB) |
None |
None |
PREA |
Sodium sulfate, potassium sulfate, and magnesium sulfate - Suprep Bowel Prep Kit |
Sponsor: Braintree Laboratories, Inc.
|
Medical (PDF - 193 KB)
|
None |
None |
PREA |
Sodium picosulfate, magnesium oxide and anhydrous citric acid - Clenpiq
|
Ferring Pharmaceuticals Inc.
|
CDTL (PDF - 1 MB) |
None |
None |
PREA |
Sofpironium - Sofdra |
Botanix SB Inc. |
Uniview (PDF - 4 MB)
Medical (PDF - 133 KB)
|
None |
None |
PREA |
Spinosad - Natroba |
ParaPRO, LLC |
Medical (PDF - 854 KB) |
Clinical pharmacology (PDF -171KB) |
None |
PREA |
Sofosbuvir - Sovaldi |
Gilead Sciences, Inc. |
Medical and CDTL (PDF - 345 KB) |
Clinical pharmacology (PDF - 511 KB) |
None |
PREA |
Sofosbuvir - Sovaldi |
Gilead Sciences, Inc. |
Medical (PDF - 218 KB) |
None |
None |
PREA |
Sofosbuvir and velpatasvir - Epclusa |
Gilead Sciences, Inc. |
Medical (PDF - 218 KB) |
Clinical pharmacology (PDF - 511 KB) |
None |
PREA |
Sofosbuvir and velpatasvir - Epclusa |
Gilead Sciences, Inc. |
Medical (PDF - 287 KB) |
Clinical pharmacology (PDF - 4 MB) |
None |
BOTH |
Solifenacin succinate - VESIcare |
Astellas Pharma Global Development, Inc. |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 933KB) |
Statistical PDF - 960 KB) |
BOTH |
Solifenacin succinate - VESIcare |
Astellas Pharma Global Development, Inc. |
Medical (PDF - 3 MB)
CDTL (PDF - 1 MB)
|
Clinical pharmacology (PDF -2MB) |
Statistical (PDF - 960 KB) |
BOTH |
Spinosad - Natroba |
ParaPRO LLC |
Medical (PDF - 458 KB) |
None |
None |
PREA |
Sulfur Hexafluoride Lipid-Type A Microspheres) for Injectable Suspension - Lumason |
Bracco Diagnostics Inc. |
Medical (PDF - 5 MB) |
Clinical pharmacology (PDF -2MB) |
Statistical (PDF -792KB) |
PREA |
Sulfur Hexafluoride Lipid-Type A Microspheres - Lumason |
Bracco Diagnostics, Inc. |
Medical (PDF - 3MB)
CDTL (PDF - 1 MB)
|
Clinical pharmacology (PDF - 1MB) |
Statistical (PDF - 859 KB) |
PREA |
Sulfur Hexafluoride Lipid-Type A Microspheres - Lumason |
Bracco Diagnostics, Inc. |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF -843 KB) |
PREA |
Sugammadex - Bridion
|
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. |
Medical (PDF - 3 MB |
Clinical pharmacology (PDF - 2 MB)
|
Statistical (PDF - 2 MB) |
PREA |
Sumatriptan/Naproxen - Treximet |
Pernix Therapeutics |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF -843 KB)
Statistical Addendum (PDF -702 KB)
|
BOTH |
Sunitinib malate - Sutent |
C.P. Pharmaceuticals International C.V. |
CDTL (PDF - 680 KB) |
None |
None |
BPCA |
Tacrolimus - Astagraf XL |
Astellas Pharma US, Inc.
|
Medical (PDF - 749 KB) |
None |
None |
PREA |
Tadalafil - Cialis |
Eli Lilly and Company |
Medical (PDF - 1 MB) |
Clinical pharmacology (PDF - 1 MB) |
None |
BPCA |
Tapentadol - Nucynta |
Collegium Pharmaceutical, Inc. |
CDTL - DD (PDF - 9 MB) |
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF -700 KB) |
PREA |
Tavaborole - Kerydin |
Anacor Pharmaceuticals, Inc. |
Multi-disciplinary review (PDF - 2.5 MB) |
None |
None |
BOTH |
Tazarotene - Arazlo |
Bausch Health US, LLC |
Clinical (PDF - 1 MB) |
None |
None |
PREA |
Tbo-filgrastim - Granix |
Sicor Biotech UAB c/o Teva Branded Pharmaceutical Products R&D |
CDTL (PDF - 176 KB)
Clinical (PDF - 196 KB)
|
Clinical pharmacology (PDF - 434 KB) |
None |
BOTH |
Technetium 99m Tilmanocept - Lymphoseek |
Cardinal Health 414, LLC |
Multidisciplinary (PDF - 2 MB) |
None |
None |
PREA |
Kit for the Preparation of Technetium Tc 99m Succimer Injection -NephroScan |
Theragnostics Inc |
Medical (PDF - 5 MB) |
None |
None |
PREA |
Tedizolid phosphate - Sivextro |
Cubist Pharmaceuticals, LLC |
Medical (PDF - 9 MB) |
None |
None |
PREA |
Teduglutide - GattexShire |
Shire-NPS Pharmaceuticals, Inc. |
Medical (PDF - 9 MB) |
None |
None |
PREA |
Tenofovir alafenamide - Vemlidy |
Gilead Sciences, Inc |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 624 KB) |
PREA |
Tenofovir disoproxil fumarate - Viread |
Gilead Sciences |
Medical (PDF - 2 MB) |
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF - 1 MB) |
PREA |
Tenofovir disoproxil fumarate - Viread |
Gilead Sciences |
CDTL (PDF - 873 KB) |
Clinical pharmacology (PDF - 180 KB) |
Statistical (PDF - 149 KB) |
BOTH |
Teplizumab-mzwv -Tzield |
Provention Bio, Inc. |
CDTL (PDF - 5 MB)
Medical (PDF - 284 KB)
|
Clinical pharmacology (PDF - 6 MB) |
None |
PREA |
Teriflunomide - Aubagio |
Sanofi |
CTDL (PDF - 3 MB)
Clinical (PDF - 3 MB)
|
Clinical pharmacology (PDF - 2 MB) |
Statistical (PDF - 410KB) |
BOTH |
Tetracaine hydrochloride - Steri-Unit |
Alcon Research, Ltd. |
DD Medical Summary (PDF - 2 MB)
Medical (PDF - 1 MB)
|
Clinical pharmacology (PDF - 158 KB) |
Statistical (PDF - 2 MB) |
PREA |
Tetracaine HCl and Oxymetazoline HCl - Kovanaze |
St. Renatus, LLC |
Medical (PDF - 12 MB) |
Clinical pharmacology (PDF - 11 MB) |
Statistical (PDF - 2 MB) |
PREA |
Tezepelumab -Tezspir
|
AstraZeneca |
Medical (PDF - 10 MB) |
None |
None |
PREA |
Ticagrelor - Brilinta
|
AstraZeneca Pharmaceuticals LP |
Medical (PDF - 10 MB) |
Clinical pharmacology (PDF - 1 MB) |
Statistical (PDF - 325 KB) |
BPCA |
Tilmanocept - Lymphoseek
|
Cardinal Health 414, LLC |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Tiotropium bromide - Spiriva Respimat |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Medical (PDF -11.9MB)
Medical Addendum (PDF - 418 KB
|
Clinical pharmacology (PDF - 6 MB) |
Statistical (PDF - 1 MB)
Statistical Addendum (PDF - 327 KB)
|
PREA |
Tiotropium bromide - Spiriva Respimat |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Medical (PDF - 5 MB) |
Clinical pharmacology (PDF - 2MB) |
Statistical (PDF - 432K B) |
BOTH |
Tobramycin 300 mg/4mL inhalation solution - Bethkis |
Cornerstone Therapeutics |
Medical (PDF - 5 MB) |
Clinical pharmacology (PDF - 78 KB) |
Statistical (PDF - 687 KB) |
PREA |
Tocilizumab - Actemra
|
Genentech, Inc. |
Medical (PDF - 72 KB)
Medical (PDF - 109 KB)
|
Clinical pharmacology (PDF - 195 KB) |
None |
PREA |
Tocilizumab - Actemra
|
Genentech, Inc. |
Medical (PDF - 8 MB) |
None |
None |
BOTH |
Tocilizumab-bavi - Tofidence |
Biogen MA Inc |
Medical (PDF - 5 MB) |
None |
None |
PREA |
Tocilizumab-aazg -Tyenne |
Fresenius Kabi USA, LLC |
CDTL (PDF - 42K B)
Medical (PDF - 8 MB)
|
None |
None |
PREA
|
Tofacitinib - Xeljanz |
Pfizer, Inc. |
Medical (PDF - 8 MB) |
None |
None |
PREA |
Topiramate - Topamax |
Janssen Pharmaceuticals, Inc. |
Medical (PDF - 8 MB) |
None |
Statistical (PDF - 881 KB) |
PREA |
Topiramate - Eprontia
|
Azurity Pharmaceuticals, Inc. |
Medical (PDF - 669 KB) |
Clinical pharmacology (PDF - 565 KB) |
None |
PREA |
Trabectedin - Yondelis |
Janssen Products, LP |
Medical (PDF - 3 MB) |
Clinical pharmacology (PDF - 683 KB) |
None |
BPCA |
Trace elements injection 4 - Tralement |
American Regent, Inc. |
Medical (PDF - 2.5 MB) |
None |
None |
PREA |
Trace elements injection 4 - Tralement |
American Regent, Inc. |
Medical (PDF - 321 KB) |
None |
None |
PREA |
Tralokinumab-ldrm - Adbry |
LEO Pharma A/S c/o LEO Pharma Inc |
Unireview (PDF - 4MB)
Medical (PDF - 32 KB)
|
None |
None |
PREA |
Trametinib - Mekinist |
Novartis Pharmaceuticals Corporation
|
Medical (PDF - 18 MB) |
None |
None |
PREA |
Trametinib - Mekinist |
Novartis Pharmaceuticals Corporation |
Medical (PDF - 800 KB) |
Clinical pharmacology (PDF - 616 KB) |
None |
BPCA |
Tranexamic acid - Lysteda |
Ferring Pharmaceuticals, Inc. |
None |
Clinical pharmacology (PDF - 1 MB) |
None |
PREA |
Tretinoin lotion - Altreno |
Dow Pharmaceutical Sciences, Inc. |
Medical (PDF - 3 MB) |
None |
None |
PREA |
Tretinoin and benzoyl peroxide - Twyneo |
Sol-Gel Technologies Ltd. c/o B&H Consulting Services Inc. |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Trifarotene - Aklief |
Galderma Research and Development |
Medical (PDF - 3 MB) |
None |
None |
PREA |
Trofinetide - Daybue |
Acadia Pharmaceuticals Inc |
Medical (PDF - 212 KB)
Medical (PDF - 6 MB)
|
Clinical pharmacology (PDF - 6 MB) |
Statistical (PDF - 2 MB)
Statistical Errata (PDF - 28 KB)
|
BPCA |
Tropicamide and phenylephrine - MYDCOMBI |
Eyenovia, Inc. |
CDTL - DD (PDF - 6 MB) |
None |
Statistical (PDF - 2 MB) |
PREA |
Upadacitinib - Rinvoq |
AbbVie Inc. |
Medical (PDF - 10 MB) |
None |
None |
PREA |
Upadacitinib - Rinvoq and Rinvoq LQ |
AbbVie Inc. |
Medical (PDF - 4 MB) |
None |
None |
PREA |
Ustekinumab - Stelara |
Janssen Biotech, Inc. |
Medical (PDF - 352 MB) |
Clinical pharmacology (PDF - 3 MB) |
None |
PREA |
Ustekinumab - Stelara |
Janssen Biotech, Inc. |
Medical (PDF - 8 MB) |
None |
None |
PREA |
Ustekinumab-aekn - Selarsdi |
Alvotech USA Inc. PharmaLex US Corporation |
CDTL (PDF - 123 KB)
Medical (PDF - 5 MB)
|
Clinical pharmacology (PDF - 9 KB) |
None |
PREA |
Valganciclovir hydrochloride - Valcyte |
Roche Palo Alto LLC c/o Genentech, Inc.orporated |
Medical (PDF - 3 MB) |
Clinical pharmacology (PDF - 6 MB) |
None |
PREA |
Valsartan - Diovan
|
Novartis Pharmaceuticals Corporation |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Varenicline - Chantix
|
PF Prism C V |
None |
Clinical pharmacology (PDF - 3 MB) |
None |
BOTH |
Vilazodone hydrochloride - Viibryd |
Allergan Sales, LLC |
Medical (PDF - 3 MB) |
None |
None |
BOTH |
Vortioxetine - Trintellix
|
Takeda Pharmaceuticals, USA, Inc. |
Medical (PDF - 3 MB) |
None |
None |
BOTH |
Vortioxetine - Trintellix |
Takeda Pharmaceuticals, USA, Inc. |
Medical (PDF - 3 MB) |
None |
None |
BOTH |
Ustekinumab - Stelara |
Janssen Biotech Inc. |
CDTL (PDF - 593 KB)
Medical (PDF - 5 MB)
|
Clinical pharmacology (PDF - 3 MB) |
Statistical (PDF - 275 KB) |
PREA |
Vigabatrin - Sabril |
Lundbeck LLC. |
Medical (PDF - 4MB) |
Clinical pharmacology (PDF - 2.3MB) |
Statistical (PDF - 698KB) |
BOTH |
Viloxazine extended release capsules - Qelbree
|
Supernus Pharmaceuticals, Inc. |
Medical (PDF - 13 KB)
Medical (PDF - 13 MB)
|
None |
None |
PREA |
Viloxazine extended-release capsules - Qelbree |
Supernus Pharmaceuticals, Inc. |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Voriconazole - Vend |
PF PRISM C.V. |
Medical (PDF - 2 MB)
Medical PDF - 200 KB)
|
Clinical Pharmacology (PDF - 1 MB) |
Statistical (PDF - 200 KB) |
PREA |
Xenon Xe 129 hyperpolarized - XENOVIEW |
Polarean Inc. |
Medical PDF - 200 KB) |
None |
None |
PREA |
Zinc sulfate - None |
American Regent, Inc. |
Medical (PDF - 4 MB) |
None |
None |
PREA |
Ziprasidone - Geodon
|
Viatris Specialty LLC |
Medical (PDF - 2 MB) |
None |
None |
PREA |
Zolmitriptan - Zomig |
AstraZeneca Pharmaceuticals LP |
Medical (PDF - 5 MB) |
None |
Statistical (PDF - 3 MB) |
PREA |
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.